Document:

<PAGE>
                                                                    EXHIBIT 10.5

B. BRAUN MEDICAL INC.                    LEASE AGREEMENT (Contract No._________)

================================================================================

This LEASE AGREEMENT (the "Lease") is made this 12th day of May 2003 by and
between B. Braun Medical Inc., a Pennsylvania corporation ("B.Braun") whose
address is 824 Twelfth Avenue, Bethlehem, PA 18018 and Curaflex Health Services,
Inc. ("Customer"). Any reference to "Lease" shall mean this Infusion System
Lease Agreement and any and all Schedules, Supplements and Addenda attached at
any time hereto.

Curaflex Health Services, Inc.             c/o Medical Specialties
---------------------------------------    ------------------------------------
(Name of Account)                          (Customer's shipping address)

1675 Broadway Suite 900                    704 Oak Creek Drive
---------------------------------------    ------------------------------------
(Street, State and Zip Code)

Denver, Colorado 80202    58-1813486       Lombard, Illinois 60148
----------------------   --------------    ------------------------------------
                         (Federal ID #)

================================================================================

1. PRODUCTS. Subject to the terms and conditions of this Lease, B.Braun shall
furnish the following equipment (the "Leased Products") to Customer:

<Table>
<Caption>
      QUANTITY    CATALOG/ REORDER #         DESCRIPTION        PRICE PER UNIT    EXTENDED PRICE
      --------    ------------------         -----------        --------------    --------------
<S>               <C>                   <C>                     <C>               <C>
        1000           637-102          VISTA BASIC IV PUMPS       $1,502.00       $1,502,000.00

B.Braun will also credit Customer for returning the following products to B.Braun as a trade in:

        1000          TRADE INS           BAXTER 3030 PUMPS        $ (250.00)      $ (250,000.00)
</Table>

<Table>
<S>                         <C>
------------------------------------------
TOTAL EXTENDED PRICE        $1,502,000.00
    LESS TRADE-IN           $ (250,000.00)
NET EXTENDED PRICE          $1,252,000.00
LEASE FINANCE CHARGE        $  139,723.20
EXTENDED LIMITED WARRANTY   $   96,000.00
                            -------------
TOTAL LEASE AMOUNT          $1,487,723.20
-----------------------------------------
</Table>

     Customer shall ship or cause to be shipped all trade-in products to B.Braun
     within seventy-five (75) days of its receipt of the Leased Products. If the
     trade-in products are not sent to B.Braun as required herein, Customer will
     not receive a trade-in credit for the amount of the shortfall, and the
     trade-in credit will be reduced appropriately, and this Lease will be
     amended to reflect the adjusted Lease Finance Charge, Total Lease Amount,
     and Monthly Lease Payments. Customer represents and warrants that it or one
     of its affiliates has good and marketable title to the trade-in products
     and that such products shall be shipped to B.Braun, free and clear of all
     liens and encumbrances.

2. LEASE CHARGE. Customer shall pay B.Braun the Total Lease Amount in equal
monthly installments as follows:

                    (a)  $15,463.59 for months 1 through 12 of the Term;

                    (b)  $35,763.14 for months 13 through 24 of the Term; and

                    (c)  $72,749.93 for months 25 through 36 of the Term

(the "Monthly Lease Payments"). For each month, B.Braun shall deliver to
Customer an invoice reflecting the Monthly Lease Payment due for such month.
Payment terms of each Monthly Lease Payment shall be net thirty (30) days
irrespective of the payment terms set forth on any invoice provided by B.Braun.
Customer shall make all Monthly Lease Payments regardless of whether Customer
receives an invoice from B.Braun. In addition to the Total Lease Amount,
Customer shall pay and be solely liable for any and all applicable sales, use,
privilege, excise, personal property or other taxes imposed or levied in
connection with this Lease or the Leased Products, whether federal, state or
local, and such taxes shall be separately stated in the monthly invoice provided
by B.Braun.

If Customer fails to pay any Monthly Lease Payment when due under this Lease,
then, in addition to paying the Monthly Lease Payment, Customer shall pay
B.Braun a late charge equal to five percent (5%) of the Monthly Lease Payment
that is delinquent until such Monthly Lease Payment is paid (and such late
charge shall be included in the Total Lease Amount due under this Lease).
Customer agrees that the late charge is a reasonable approximation of the
internal administrative costs incurred by B.Braun as a result of Customer's
delinquency in the timely payment of a Monthly Lease Payment. Customer shall be
liable for and shall reimburse B.Braun for its reasonable costs and attorneys'
fees and expenses incurred by B.Braun for collection of overdue amounts or
enforcement of its rights under this Lease.

This Lease is a non-cancelable net lease, and Customer's obligations to pay the
Total Lease Amount and other amounts due hereunder are absolute and
unconditional. Customer shall not be entitled to any abatement, reduction or
offset with respect to its obligations under this Lease. Notwithstanding the
foregoing, if Customer is not in default of any of its obligations under this
Lease, Customer may elect to purchase the Leased Products at any time during the
Term of this Lease at a purchase price determined by B.Braun, upon Customer's
request. Such sale shall be on an "as-is, where-is" basis without any recourse
to or representation or warranty by B.Braun, and the purchase price shall be due
and payable in immediately available funds.

3. TERM. The Term shall be for a period of thirty-six (36) months commencing on
the first day of the month after shipment of the Leased Products from B.Braun to
Customer and ending on the last day of the 35th month thereafter (the "Term"),
unless or until sooner terminated in accordance with the terms hereof.

4. PURCHASE OPTION; RETURN OF LEASED PRODUCTS. By providing at least thirty (30)
days written notice to B.Braun, Customer shall have the continuing option,
exercisable from time to time during the Term of this Lease to purchase all or a
portion of the Leased Products from B.Braun. Upon request by Customer of its
desire to purchase any of the Leased Products prior to expiration of the Term,
B.Braun will provide Customer with (a) a price per unit as of the effective date
of the purchase (plus the remaining balance owed on the Extended Limited
Warranty for such Leased Products being purchased), which must be paid in full,
and (b) an amendment to this Lease, which will set forth the Monthly Lease
Payments for the remaining Term. All outstanding amounts then owed under this
Lease must be paid in full prior to B.Braun's obligation to sell any of the
Leased Products to Customer. Upon full payment of the purchase price of the
Leased Products purchased by Customer and any and all then outstanding amounts
due under this Lease (including late charges, penalties and interests, if any),
B.Braun

                                       1
<PAGE>

shall deliver to Customer a bill of sale for the Leased Products purchased by
Customer, which shall indicate that such purchase by Customer is on an "as is,"
"where is" basis and without any recourse to or representation or warranty by
B.Braun (except for the Product Warranty, as defined in paragraph 6 of this
Lease). Customer shall be solely liable for any sales, use or similar taxes
imposed in connection with the purchase of the Leased Products under this Lease.
If, upon expiration of the Term, Customer has paid all amounts due under this
Lease (including late charges, penalties and interests, if any) Customer shall
be deemed to have elected to purchase all of the Leased Products, at a purchase
price of $1.00 per unit, which have not been purchased from B.Braun as of the
expiration of the Term, unless within thirty (30) days prior to the expiration
of the Term, Customer has advised B.Braun that it does not intend to purchase
some or all of the remaining Leased Products hereunder.

If Customer does not purchase the Leased Products at the expiration of the Term
or any extension of this Lease, or if B.Braun terminates this Lease under
Section 11, then, within ten (10) days after termination, Customer, at its sole
cost and expense, shall return the Leased Products to B.Braun in good working
condition (normal wear and tear excepted) by delivering the Leased Products,
adequately packaged, addressed, and insured against loss in transit, to B.Braun
at such location as B.Braun shall specify in writing to Customer. Any Leased
Products to be returned to B.Braun as part of a "trade in" or other exchange of
leased products shall be returned within thirty (30) days after receipt of such
new leased products.

If Customer fails to purchase or return the Leased Products, as applicable, then
Customer shall be deemed to have elected to renew the Term on a month-to-month
basis upon the same terms as set forth herein, except that B.Braun shall have
the right at any time after the deemed election to terminate this Lease upon ten
(10) days' prior notice to Customer, in which event, Customer shall, at its sole
cost and expense, promptly return the Leased Products to B.Braun in good
working condition (normal wear and tear excepted) by delivering the Leased
Products, adequately packaged, addressed, and insured against loss in transit,
to B.Braun at such location as B.Braun shall specify in writing to Customer.

5. MAINTENANCE AND REPAIRS. Customer shall at all times during the Term and at
its sole cost and expense, maintain the Leased Products in good working
condition and repair, reasonable wear and tear excepted. Customer immediately
shall notify B.Braun of any repairs or replacements of the Leased Products that
are necessary and shall not, without the prior authorization of B.Braun, make
any such repairs or replacements. Any replacement parts, changes in or
improvements to the Leased Products shall become and remain the sole property of
B.Braun. B.Braun will not be responsible at any time for the cost of repairs or
replacement of the Leased Products resulting from the negligent or intentional
acts of, or misuse by, Customer or from any services performed by persons other
than B.Braun or its authorized agent

6. WARRANTY. The product warranty, and the Extended Limited Warranty
(collectively, the "Product Warranty") made by B.Braun is attached hereto and
made a part of this Lease. The Total Lease Amount includes the cost of the
Extended Limited Warranty during the period from the second anniversary of this
Lease through the third anniversary, and is provided in accordance with the
terms and conditions of the Extended Warranty Program Agreement attached hereto.

7. DELIVERY. B.Braun shall deliver the Leased Products to Customer at the
shipping address noted above. Shipment of the Leased Products by B.Braun will be
made F.O.B. origin. All shipping dates quoted whether verbal or written are
approximate and are based upon prompt receipt by B.Braun of all necessary
information from Customer. B.Braun shall not be liable to Customer for any
delays in the delivery of the Leased Products.

8. TITLE/LOCATION/USE.

(a) TITLE; SECURITY INTEREST

Title to the Leased Products shall at all times remain with B.Braun. This Lease
is intended by B.Braun and Customer to be a lease and not a sale, but to the
extent, at any time or from time to time, this Lease is construed or asserted to
be a transaction intended as security, B.Braun retains and/or Customer hereby
grants to B.Braun a first lien security interest in and to all of the Leased
Products, the proceeds of any sale thereof, assignment, lease or sublease
thereof, any insurance proceeds, and any other rights of Customer in and to the
Leased Products, this Lease and/or their proceeds. The parties understand and
agree that, unless otherwise specified herein, Customer does not acquire, under
this Lease, any right, title or interest in or to the Leased Products, except
the right to possess and use the Leased Products during the Term so long and
only so long, as there is no Event of Default continuing with respect to
Customer. Unless and until the Leased Products are purchased and paid for by
Customer pursuant to Section 2 or 4 of this Lease, the Leased Products are, and
shall remain at all times, the personal property of B.Braun regardless of how
they are or may become attached or installed by Customer. In order to protect
B.Braun's security interest in the Leased Products, Customer hereby authorizes
B.Braun (or B.Braun's agent) to file any UCC-1 forms, financing statements or
other forms to evidence B.Braun's rights to, interest in, and claims upon the
Leased Products. Customer agrees to reimburse B.Braun for any expenses incurred
by B.Braun in preparing and filing any such financing statements or forms and
for B.Braun's other documentation costs in connection with this Lease.

(b) LOCATION, USE, INSPECTION

On every June 1st and December 1st during the Term, and if requested by
B.Braun at any other time, Customer will submit a report to B.Braun that
identifies the location of the Equipment, by serial number, as of the date of
such report. Customer shall be responsible for maintaining accurate records,
which shall include the identification by serial number and location for each
Leased Product, in accordance with the United States Food and Drug
Administration ("FDA") rules and regulations. Customer shall use and/or operate
the Leased Products in a careful and lawful manner, and shall not make any
alterations or additions to the Leased Products without the prior written
consent of B.Braun. Customer shall use the Leased Products only for the purposes
and in accordance with the instructions indicated on the labeling of or included
with the Leased Products. B.Braun retains the right to inspect the Leased
Products at any time upon reasonable notice to Customer to ensure compliance
with the provisions of this Lease and all applicable laws. Customer certifies
and warrants that the Leased Products are for its own use and Customer will not
sell or otherwise transfer the Leased Products without the prior written consent
of B.Braun. Customer agrees to notify B.Braun, in writing, as to the change in
Customer's legal name, fictitious or d/b/a name, and address. Any failure by
Customer to notify B.Braun of any such change shall, at B.Braun's election, be
deemed a material breach of this Lease.

(c) LOSS OR DAMAGES

Customer shall bear the entire risk of loss or theft, destruction or damage of
the Leased Products from any cause whatsoever, which loss or damage occurs after
B.Braun delivers the Leased Products to Customer. No such event shall relieve
Customer of its obligations to pay Monthly Lease Payments or any charges then
outstanding or as may become due under this Lease.

(d) LIENS AND TAXES

Customer shall at all times during the Term protect and defend, at its own cost
and expense, the title of B.Braun in the Leased Products from and against all
claims, liens, encumbrances and legal processes ("Encumbrances") of Customer's
creditors, and shall keep all Leased Products free and clear from all
Encumbrances.

                                       2
<PAGE>

Customer shall also prepare and file all applicable tax returns relating to the
ownership, use, lease or possession of the Leased Products and shall pay all
taxes when due, including without limitation, all excise and property taxes, and
upon reasonable request of B.Braun, shall furnish B.Braun with evidence of such
filing.

(e) MODIFICATIONS, ALTERATIONS

Customer shall make no alterations in, or attachments to, the Leased Products,
without the prior written consent of B.Braun. In addition, Customer shall not
remove, alter, or cover any trademarks, tradenames, labels, signs, symbols or
serial numbers that are, or may be attached to the Leased Products by or at the
request of B.Braun. Notwithstanding the foregoing sentence, Customer may mark
the Leased Products with its own identifiers to meet its own internal tracking
requirements.

9. INSURANCE. Customer shall at all times during the Term maintain, at its sole
cost and expense, insurance against (i) loss, theft, destruction or damage of or
to the Leased Products and (ii) third party liability insurance in amounts and
with exclusions and deductions acceptable to B.Braun. All such insurance shall
be underwritten by insurance companies and on such terms as are satisfactory to
B.Braun. Upon request, Customer shall provide B.Braun with satisfactory evidence
of such insurance and, if requested by B.Braun, shall cause B.Braun and its
successors and assigns to be named as a loss payee or additional insured on such
policies. During the Term, Customer shall not terminate amend or modify such
insurance without the prior written consent of B.Braun. No insurance shall be
subject to any co-insurance clause and Customer shall be obligated to maintain
insurance under this Lease as primary coverage for B.Braun and irrespective of
any insurance maintained by B.Braun on the Leased Products.

10. FORCE MAJEURE. B.Braun shall be excused from any delay in, or impossibility
of, performance due to any cause beyond its or its supplier's or
sub-contractor's control, acts of God, war, acts of government, regulatory
agencies or judicial bodies, acts of Customer or third parties, raw materials
shortages, energy or fuel shortages, fire, flood, strike or labor trouble,
sabotage, or delays in manufacturing or delays in obtaining labor, materials,
equipment or transportation. In the event of any such delay, B.Braun may
allocate the products among all of its customers, without penalty or liability.

11. DEFAULT AND DEFAULT REMEDIES. The following shall constitute an Event of
Default under this Lease: (a) Customer repudiates this Lease for any reason, (b)
Customer fails to use or operate the Leased Products in a careful and lawful
manner and in a manner consistent with their intended purpose, (c) Customer
fails to protect B.Braun's property rights in and to the Leased Products, (d)
Customer fails to maintain required property and liability insurance as required
by Section 9 of this Lease, (e) Customer winds up, dissolves, or otherwise
terminates its existence, or consolidates or merges with or into another entity
or sells, leases or transfers all or substantially all of its assets to any
entity, (f) Customer becomes or is adjudicated insolvent or bankrupt, admits in
writing its inability to pay its debts or makes an assignment for the benefit of
credits, or there is an appointment of a receiver or trustee for Customer or for
a substantial part of its assets, or Customer institutes any bankruptcy or
reorganization under the laws of any jurisdiction or any such proceeding is
instituted against Customer, (g) Customer fails to make any Monthly Lease
Payment or any other amount payable to B.Braun under this Lease when such
payment is due, (h) Customer is in breach of any provision of this Lease or
Customer fails to perform any other of its obligations under this Lease, or
there occurs an event under clauses (b), (c) (d), (g) or (i) of this paragraph,
and such failure continues for ten (10) days after B.Braun gives Customer
written notice of such failure and Customer fails to cure such breach or failure
to B.Braun's satisfaction within such ten (10) day period, or (i) Customer is in
default under any document, lease or other agreement or instrument evidencing
obligations of Customer or any of its affiliates to B.Braun, whether now
existing or hereafter existing, which default remains uncured beyond the
expiration of any applicable grace or cure period.

Upon an Event of Default, B.Braun, at its sole discretion and without further
notice to Customer, may (in addition to other remedies available at law or
equity) undertake any or all of the following remedies: (a) recover from
Customer any further amounts then due as of the date of the Event of Default and
declare due and payable any unpaid Total Lease Amount and all amounts which
would have become due if this Lease had remained in effect for the full Term
following such Event of Default; (b) demand the return of the Leased Products to
B.Braun in the manner set forth in Section 4 of this Lease; (c) take immediate
possession of the Leased Products wherever located, without demand or notice,
without any court order or other process of law, and without any liability to
Customer for any damages occasioned by such taking, it being agreed that B.Braun
may enter the premises of Customer where the Leased Products are maintained to
remove the Leased Products; (d) terminate this Lease by notice to Customer;
provided that, a termination hereunder shall occur only with respect to the
Leased Products specified in such written notice and in all other respects, this
Lease shall continue in full force and effect and Customer shall be obligated to
perform all acts and to pay all amounts when due with respect the Leased
Products for which this Lease was not terminated; and/or (e) pursue any other
remedy available at law or in equity.

No right or remedy herein conferred upon or reserved to B.Braun is exclusive of
any other right or remedy herein or provided by law or at equity, but each such
remedy shall be cumulative of every other right or remedy, and may be enforced
concurrently or sequentially. If an Event of Default occurs under this Lease
prior to confirmation of a plan of reorganization in Bankruptcy Case No.
00-3329, the trustee in such bankruptcy case and Customer agree not to oppose
B.Braun in obtaining relief from the automatic stay under 11 U.S.C. Section 362
to exercise any of its rights under the terms of this Lease or applicable law.

12. INDEMNIFICATION. Except for liabilities arising from a breach of the Product
Warranty by B.Braun (prior to the expiration thereof), Customer hereby accepts
responsibility for, and indemnifies and holds B.Braun and its successors and
assigns harmless from and against, any and all liabilities, damages and claims
(including, without limitation, expenses of litigation, investigators and
attorney's fees, settlements and damages) arising from or related to Customer's
acceptance, leasing, purchase by Customer, possession, maintenance, selection,
use or operation of the Leased Products, including without limitation and by way
of example, any failure to utilize appropriate type(s) of Leased Products for a
given patient or type of IV administration, failure to observe the Leased
Product's audio or visual alarms during IV administration, or failure to observe
proper set-up, operation and supervision procedures prior to, during and after
IV administration. Customer's obligations hereunder shall survive the
termination of this Lease.

B.Braun indemnifies and holds Customer and its successors and assigns ("Customer
Parties") harmless from and against any and all liabilities damages and claims
(including, without limitation, expenses of litigation, investigators' and
attorneys' fees, settlements and damages asserted by persons other than Customer
Parties arising from or related to defects in materials and/or workmanship of
the Leased Products, except to any extent due to the acts or omissions of
Customer Parties or any other party, failure to use or maintain the Lease
Products in accordance with their instructions, or any modification or
alteration made to the Leased Products by Customer Parties or any other party,
other than B.Braun. Customer shall immediately submit all such claims to B.Braun
and B.Braun shall control the defense thereof. If Customer desires to join any
defense of such claim, it shall be entitled to do so at its sole cost and
expense. Customer agrees to cooperate with B.Braun and its counsel.

                                       3
<PAGE>

13. COMPLIANCE WITH LAWS.

(a) COMPLIANCE

Customer shall comply with all applicable laws, ordinances, rules and
regulations of federal, state and local government authorities and/or agencies
applicable to this Lease or the purchase, operation, condition, maintenance or
use of the Leased Products.

(b) REIMBURSEMENT

IF ANY PRICING UNDER THIS LEASE CONSTITUTES A DISCOUNT OR OTHER REDUCTION IN
PRICE UNDER SECTION 1128(b)(3)(A) OF THE SOCIAL SECURITY ACT, 42 U.S.C.
1320a-7b(b)(3)(A), CUSTOMER SHALL DISCLOSE THE DISCOUNT OR REDUCTION IN PRICE TO
THE FULL EXTENT REQUIRED UNDER ANY STATE OR FEDERAL PROGRAM WHICH PROVIDES COST
OR CHARGE BASED REIMBURSEMENT TO CUSTOMER FOR ANY PRODUCTS COVERED UNDER THIS
LEASE. THIS ACT REQUIRES, AMONG OTHER THINGS, THAT CUSTOMER FULLY AND ACCURATELY
REPORT ON ANY CLAIM OR REQUEST FOR PAYMENT IT SUBMITS TO MEDICARE AND MEDICAID
THE ACTUAL PURCHASE PRICE PAID BY CUSTOMER FOR THE LEASED PRODUCTS, NET OF ANY
DISCOUNTS, REBATES OR ALLOWANCES PROVIDED TO CUSTOMER UNDER THIS LEASE.

(c) REPORTING

Customer acknowledges that it is familiar with the Safe Medical Devices Act of
1990 (the "Devices Act") and the reporting obligations imposed on device users
thereunder. In this regard, Customer agrees to notify B.Braun within ten (10)
days of the occurrence of any event identified in the Devices Act imposing a
reporting obligation on Customer and/or B.Braun (except for events representing
an imminent hazard that requires notification to the FDA within seventy -two
(72) hours, in which case, such notice will be delivered to the other party
immediately upon receipt).

(d) DEVICE TRACKING

Customer shall maintain adequate tracking systems for the Leased Products to
enable B.Braun to meet the FDA requirements applicable to the tracking of
medical devices.

14. MISCELLANEOUS.

(a) LIMITATION OF LIABILITY

In no event shall B.Braun be liable to Customer for any indirect, incidental,
special, consequential or punitive damages (including damages for lost profits)
arising out of or in connection with the delivery, use or service of the Leased
Products or the performance, use or inability to use the Leased Products or
otherwise, whether based in contract, warranty, tort (including negligence) or
any other legal or equitable theory. B.Braun's total liability for any claim or
action arising out of or related to this Lease or the Leased Products shall not
in any event exceed the Total Extended Price.

(b) GOVERNING LAW

This Lease, including any warranties, and any dispute or claim arising out of or
relating to this Lease or the Leased Products shall be governed by the laws of
the Commonwealth of Pennsylvania excluding any choice of law rules which may
direct the application of the laws of any other jurisdiction. Any suits,
actions, claims, causes of action or proceedings arising directly, indirectly or
otherwise in connection with, out of, or related to, this Lease, the Leased
Products, any dealings between B.Braun and Customer relating to the subject
matter hereof and/or the relationship established between B.Braun and Customer
under this Lease (each, an "Action") shall be brought, at B.Braun's sole
discretion and election, in the courts situated within the Commonwealth of
Pennsylvania and Customer hereby consents and submits to the jurisdiction of any
state or federal court located within the Commonwealth of Pennsylvania. Customer
hereby waives any right it may have to transfer or change the venue of any
Action. CUSTOMER HEREBY UNCONDITIONALLY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY
ACTION, AND ACKNOWLEDGES AND AGREES THAT THE SCOPE OF THIS WAIVER IS INTENDED TO
BE ALL ENCOMPASSING OF ANY AND ALL ACTIONS THAT MAY BE FILED IN ANY COURT.
CUSTOMER ACKNOWLEDGES THAT IT HAS BEEN INFORMED THAT THIS SECTION 14(b)
CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH B.BRAUN IS RELYING IN ENTERING INTO
THIS LEASE.

(c) AMENDMENTS

Any term may be amended and the observance of any term may be waived (either
generally or in a particular instance and either retroactively or prospectively)
only with the written consent of B.Braun and Customer. The failure of B.Braun in
any instance to exercise any of its rights under this Lease shall not constitute
a waiver of it or any other right under this Lease. No waiver of any breach or
condition of this Lease shall be deemed to be a waiver or breach of any other or
a subsequent breach or condition whether of like or different nature. No changes
in this Lease, including any conflicting or additional terms contained in any
purchase order, invoice or other document submitted by Customer, shall be valid.

(d) ASSIGNMENT

Customer may not assign, transfer, pledge, hypothecate, encumber, sublease,
grant a security interest in or otherwise dispose of Customer's interest in this
Lease, the Leased Products or any interest therein, or permit the Leased
Products to be used by anyone other than Customer or its authorized personnel,
in each instance, without the prior written consent of B.Braun. B.Braun's
consent to any of the foregoing shall not discharge or diminish Customer's
obligations under this Lease and any person's rights with respect to this Lease
and the Leased Products shall be expressly made subject and subordinate to the
rights of B.Braun under this Lease. B.Braun shall have the right at any time to
assign (including title to the Leased Products) or grant a security interest in
this Lease or the Leased Products or any part or parts thereof for any purpose
without notice to, or consent by, Customer. Any assignee or secured party shall
have the same rights as B.Braun under this Lease. Customer shall not assert
against any assignee or secured party any defense, claim or set-off Customer may
have against B.Braun and any assignee or secured party shall not be liable or
responsible to perform any of B.Braun's obligations under this Lease. Customer's
duties and obligations under this Lease shall not be effected by any assignment
of this Lease and Customer shall, if requested, recognize each such assignment
or grant of a security interest and upon reasonable notice from B.Braun, shall
execute and deliver such documents as B.Braun reasonably believes are necessary
to effect such assignment. Customer hereby expressly waives any protections
available under 11 U.S.C. Section 365(f).

(e) BINDING EFFECT

The obligations and liabilities of Customer arising under this Lease shall
survive the expiration or earlier termination of this Lease until all
obligations have been met and all liabilities have been paid in full. This Lease
shall be binding upon and inure to the benefit of B.Braun and Customer and each
of their respective successors and permitted assigns including without
limitation, any successor of Customer's by way of merger, consolidation or sale
of all or substantially all of its assets or equity.

(f) REPRESENTATIONS OF THE PARTIES

Each party hereby represents to the other party that (i) it has the right to
enter into this Lease and to perform all of its obligations hereunder, (ii) this
Lease when executed and delivered by the party, will be a legal, valid and
binding obligation of such party, enforceable against it in accordance with its
terms; and (iii) neither the

                                       4
<PAGE>

execution of this Lease by such party nor the performance of its obligations
hereunder conflicts with or contravenes any other contract, agreement, lease or
instrument to which such party is a party or by which such party or its assets
are bound.

(g) SEVERABILITY

If any clause or provision of this Lease or the application thereof to any
person or circumstance is conclusively determined by a court of competent
jurisdiction to be invalid or unenforceable to any extent, the remainder of this
Lease and the application thereof shall not be affected thereby and shall be
enforced to the fullest extent permitted by applicable law.

(h) ENTIRE LEASE

This Lease, the Warranty, the Extended Warranty Program Agreement, and any
addenda, schedules, attachments and supplements now or hereafter attached
hereto, as the same may be amended from time to time, constitutes the entire
agreement between the parties hereto with respect to the Leased Products
irrespective of any inconsistent or additional terms and conditions on
Customer's purchase orders or other documents. Customer understands and agrees
that any terms and conditions outside of this Lease shall be without force and
effect. All prior negotiations, representations, discussions, contracts or
agreements concerning the subject matter hereof, whether express or implied,
oral or written, are cancelled and of no force and effect.

(i) NOTICES

Any notice or other communication required or which may be given hereunder shall
be in writing and either be delivered personally (by hand, messenger or other
overnight courier service), or deposited in the United States mail, first class,
certified, return receipt requested, postage prepaid, and shall be deemed given
(i) when delivered, if delivered personally, (ii) one business day if delivered
by overnight courier service, or (iii) three (3) business days after the date of
deposit in the United States mail, if mailed; and shall be addressed to B.Braun
and Customer at the street addresses set forth in the beginning of this Lease.
Either party may change its address to which notices or other communications are
to be sent by giving written notice of any such change to the other party in the
manner provided herein for giving notice.

(j) [INTENTIONALLY OMITTED]

(k) BANKRUPTCY COURT APPROVAL AND ASSUMPTION OF AGREEMENT

This Lease shall not become effective unless and until the United States
Bankruptcy Court for the District of Delaware enters a final Order in a form
reasonably satisfactory to B.Braun approving the terms and conditions of the
Continuing Guaranty and Suretyship of Coram Healthcare Corporation and Coram,
Inc., which jointly and severally, are guarantors and suretys of the obligations
of Customer under this Lease. B.Braun's obligations under this Lease are
contingent upon B.Braun's satisfaction with the Court's Order.

(l) COUNTERPARTS

This Lease may be executed in one or more counterparts, all of which shall
constitute one original agreement for all purposes. Any and all counterpart
signatures may be executed by facsimile or electronic means and any signature so
executed shall be deemed an original signature of the executing party.

By execution hereof, Customer agrees to be bound by all of the terms and
conditions of this Lease. This Lease does not become effective unless and until
it is executed by B.Braun

IN WITNESS WHEREOF, B.Braun and Customer have executed this Lease Agreement as
of the date first above written.

CUSTOMER: CURAFLEX HEALTH SERVICES, INC.      B.BRAUN MEDICAL INC.

By:    /s/ Frank Geiger                       By:   /s/ Scott Quilty
       ---------------------------------            ---------------------------
       Signature                                    Signature

Name:  Frank Geiger                           Name  Scott Quilty
       ---------------------------------            ---------------------------
       (Type or print name)                         (Type or print name)

Title: Senior Vice President                  Title Vice President, OPM Sales
       Materials Management                         ---------------------------
       ---------------------------------

------------------------------------     --------------------------------------
FOR INTERNAL USE ONLY:

Shipping Date                            ADDITIONAL FORMS ATTACHED:
              ---------------------
Lease Payment Start Date                 X  Warranty
                        -----------
Expiration Date                          X  Extended Warranty Program Agreement
                -------------------
Repair Authorization
                     --------------
Other
      -----------------------------
------------------------------------     --------------------------------------

                                       5
<PAGE>
================================================================================

                             B. BRAUN MEDICAL INC.
                        Vista(TM) Basic Infusion Device
                                PRODUCT WARRANTY

B. Braun Medical Inc. ("B.Braun") warrants to and only to the original purchaser
or lessee ("Customer") of the Vista(TM) Basic Infusion Device ("Equipment") that
reasonable care has been used in the manufacture of each unit of Equipment and
that, when properly used and maintained by Customer, it shall be free from
defects in material and workmanship in accordance with its specifications for a
period of two (2) years from the date of shipment of such Equipment by B.Braun
("Warranty Period"). Any unit of Equipment that is found by B.Braun not to meet
these standards within this Warranty Period will, at B.Braun's sole option, be
repaired or replaced without charge. Any defective unit of Equipment or
component thereof should be returned promptly to B.Braun, properly packaged and
with postage prepaid by Customer. Customer shall provide labor for the removal
of defective Equipment and installation of its replacement, and shall bear all
risk of loss or damage while in transit. In the event no breach of warranty is
discovered by B.Braun upon receipt of any returned item, the item will be
returned to Customer at Customer's expense.

This Warranty is valid only if the Equipment is operated and maintained as
described in B.Braun's operator's manuals, supplements or other operating
instructions. This Warranty shall not apply to any Equipment or component
thereof if (1) any repairs, alterations, or other work has been performed on the
Equipment or any component thereof by anyone other than B.Braun or a technician
or repair facility authorized in writing by B.Braun; (2) the Equipment is
altered in any manner that, in B.Braun's sole judgement, affects its stability
or reliability; (3) the alleged condition or defect is a result of the misuse,
improper cleaning or improper handling, negligence, accident or improper
maintenance of any party; (4) the Equipment is not used in accordance with its
instructions for use furnished by B.Braun or is not used for its intended
purpose.

Any defect or condition that has been caused by the misuse, unauthorized
modification, or abnormal conditions of operation, or that is otherwise excluded
from this Warranty, will be repaired by B.Braun at its then current repair
charges. In this case, upon the request of Customer, B.Braun will submit an
estimate of the repair cost to Customer prior to making any repairs. This
Warranty does not extend to damages to, or resulting in whole or in part from
the use of, components, accessories, parts or supplies not supplied by B.Braun
for use with the Equipment. Products or components not manufactured by B.Braun
are not warranted by B.Braun, and Customer must rely on the warranties, if any,
provided directly be the manufacturer of such product or component.

EXCEPT AS EXPRESSLY PROVIDED HEREIN, B.BRAUN MAKES NO WARRANTY OF ANY KIND,
EXPRESS OR IMPLIED BY OPERATION OF LAW OR OTHERWISE WITH RESPECT TO THE
EQUIPMENT INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. The sole and exclusive
remedy of Customer for breach by B.Braun of any warranty shall be limited, at
B.Braun's sole election, to the repair or replacement of the unit of Equipment
or any component thereof. In no event shall B.Braun be liable to Customer for
any indirect, incidental, special, consequential or punitive damages (including
damages for lost profits) arising out of or in connection with the delivery, use
or service of any Equipment or the performance, use or inability to use the
Equipment or otherwise, whether based in contract, warranty, tort (including
negligence) or any other legal or equitable theory.

B.Braun neither assumes, nor authorizes any person to assume for it, any
additional liability or responsibility in connection with the Equipment and no
agent, employee or representative of B.Braun has the right to modify or expand
the warranties set forth herein and no such modification or expansion should by
relied upon by Customer.

         B. BRAUN MEDICAL INC. 824 TWELFTH AVENUE, BETHLEHEM, PA 18018
                        CUSTOMER SUPPORT 1 (800) 627-7867                2/3/03

================================================================================
<PAGE>
                             B. BRAUN MEDICAL INC.

                      EXTENDED WARRANTY PROGRAM AGREEMENT

The undersigned Curaflex Health Services, Inc. ("Customer") is leasing 1000
Vista(R) Basic IV Pumps (the "Equipment") from B. Braun Medical Inc. ("B.Braun")
under its lease agreement dated May 12, 2003, Contract No. ______________ (the
"Contract").

In connection with the Contract, Customer has elected to purchase from B.Braun
the following additional product warranty:

TYPE AND PERIOD OF WARRANTY PURCHASED BY CUSTOMER:

Extended Limited Warranty for a period of one (1) year at a purchase price of
$96.00 per unit of Equipment per year, for an aggregate purchase price of
$96,000.00 per year (said period to commence upon the second anniversary of the
Contract through the third anniversary thereof)

PAYMENT:

The applicable purchase price set forth above shall be referred to as the
"Annual Warranty Price." The Annual Warranty Price shall be paid by Customer to
B.Braun as provided in the Contract. This Extended Warranty Program Agreement is
subject to the terms and conditions in the Contract, and the Contract is hereby
incorporated herein, by reference thereto.

WARRANTY DESCRIPTION:

The Extended Limited Warranty Program provides for repair by factory trained
technicians at the manufacturing facility, subject to the terms of this
agreement. The Extended Limited Warranty shall commence immediately after
expiration of B.Braun's standard factory warranty covering such type of
equipment (which is two year from date of shipment). During the Extended Limited
Warranty period, B.Braun shall repair or replace, at B.Braun's option and at no
cost to Customer, any unit of Equipment determined by B.Braun to have defects in
material or workmanship. To initiate the repair or replacement of a defective
unit of Equipment, Customer must notify B.Braun at (800) 627-PUMP and fully
complete and deliver to B.Braun a Returned Material Authorization Form ("RMA").
All defective items must be properly packaged and shipped freight prepaid to
B.Braun at the address indicated on the RMA. Any loss or damage during shipment
of any defective Equipment to B.Braun shall be at the sole risk of Customer.
Only Equipment appearing on an RMA shall be acceptable for repair or
replacement. If B.Braun determines that any defect or condition in any unit of
Equipment has been caused by the misuse, unauthorized modification, or abnormal
conditions of operation, B.Braun shall repair the item at a cost to Customer
equal to its then current repair charges. In such case, B.Braun shall provide
Customer with an estimate of the repair cost prior to making any repairs.

WARRANTY EXCLUSIONS

The Extended Limited Warranty shall not apply:

         o        to any cosmetic upgrades, including cosmetic bezels, case
                  tops, case bottoms and key pads;

                                       1
<PAGE>

         o        if any condition or defect is a result of the misuse, improper
                  cleaning or improper handling, negligence, abuse, accident or
                  improper maintenance of any party other than B.Braun;

         o        if the Equipment and/or the repair kit is not used in
                  accordance with its instructions for use furnished by B.Braun
                  or is not used for its intended purpose;

         o        if any repairs, alterations, or other work has been performed
                  on the Equipment or any component thereof by anyone other than
                  B.Braun or a technician or repair facility authorized in
                  writing by B.Braun; or

         o        the Equipment is altered in any manner that, in B.Braun's sole
                  judgement, affects its stability or reliability;

Batteries are not included in the Extended Limited Warranty. The Extended
Limited Warranty is valid only if the Equipment is operated and maintained as
described in B.Braun's operator's manuals, supplements or other operating
instructions. This Extended Limited Warranty does not extend to damages to, or
resulting in whole or in part from the use of, components, accessories, parts or
supplies not supplied by B.Braun for use with the Equipment. Products or
components not manufactured by B.Braun are not warranted by B.Braun, and
Customer must rely on the warranties, if any, provided directly be the
manufacturer of such product or component.

Any defect or condition that has been caused by the misuse, unauthorized
modification, or abnormal conditions of operation, or that is otherwise excluded
from this Warranty, will be repaired by B.Braun at its then current repair
charges. In this case, upon the request of Customer, B.Braun will submit an
estimate of the repair cost to Customer prior to making any repairs.

EXCLUSIVE REMEDY

EXCEPT AS EXPRESSLY PROVIDED HEREIN, B.BRAUN MAKES NO WARRANTY OF ANY KIND,
EXPRESSED OR IMPLIED BY OPERATION OF LAW OR OTHERWISE WITH RESPECT TO THE
EQUIPMENT INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. THE SOLE AND EXCLUSIVE
REMEDY OF CUSTOMER FOR BREACH BY B.BRAUN OF ANY WARRANTY PURCHASED BY CUSTOMER
HEREIN SHALL BE LIMITED, AT B.BRAUN'S SOLE ELECTION, TO THE REPAIR OR
REPLACEMENT OF THE UNIT OF EQUIPMENT OR ANY COMPONENT THEREOF OR THE SERVICES
PROVIDED. IN NO EVENT SHALL B.BRAUN BE LIABLE TO CUSTOMER FOR ANY INDIRECT,
INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES (INCLUDING DAMAGES FOR
LOST PROFITS) ARISING OUT OF OR IN CONNECTION WITH THE DELIVERY, USE OR SERVICE
OF ANY EQUIPMENT OR THE PERFORMANCE, USE OR INABILITY TO USE THE EQUIPMENT OR
OTHERWISE, WHETHER BASED IN CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE) OR
ANY OTHER LEGAL OR EQUITABLE THEORY.

B.Braun neither assumes, nor authorizes any person to assume for it, any
additional liability or responsibility in connection with the Equipment and no
agent, employee or representative of B.Braun has the right to modify or expand
the warranties set forth herein and no such modification or expansion should by
relied upon by Customer.

                                       2
<PAGE>

TERM

The Extended Limited Warranty shall remain in effect for the period identified
on the front page of this agreement, unless terminated earlier by B.Braun due to
Customer's failure to pay any amounts due hereunder. In the event of termination
by B.Braun, B.Braun shall be entitled to the Annual Warranty Price for the
remainder of the warranty period as if such termination did not occur.

This Extended Warranty Program Agreement shall not become effective unless
signed below by B.Braun.

Agreed to:

CURAFLEX HEALTH SERVICES, INC.             B. BRAUN MEDICAL INC.

By: /s/ Frank Geiger                       By: /s/ Scott Quilty
   ---------------------------------          ---------------------------------
          (Customer Signature)                      (Authorized Signature)

Print Name: Frank Geiger                   Print Name: Scott Quilty
            ------------------------                   ------------------------
Title Senior Vice President,               Title Vice President, OPM Sales
      Materials Management                       ------------------------------
      ------------------------------

Date May 12, 2003                          Date May 12, 2003
     -------------------------------            -------------------------------

                                       3
<PAGE>
                       CONTINUING GUARANTY AND SURETYSHIP
                BY CORAM HEALTHCARE CORPORATION AND CORAM, INC.

         Intending to be legally bound hereby, and in consideration of B. Braun
Medical Inc. ("B.Braun") agreeing to lease 1000 Vista(R) Basic IV Pumps (the
"Leased Products") to Curaflex Health Services, Inc. ("Curaflex") under a Lease
Agreement of even date herewith (the "Lease"), Coram Healthcare Corporation and
Coram, Inc. (individually and collectively, "Guarantor"), jointly and severally,
hereby guarantee and become surety for the prompt payment and performance in
full and of all of the obligations of Curaflex to B.Braun under the Lease,
including all amounts now owed and all amounts which may be owed under the Lease
in the future, together with all attorneys' fees and all of B.Braun's other
costs of collection. Curaflex is a wholly-owned affiliate of Guarantor. In
addition to all other liabilities of the Guarantor hereunder, the Guarantor also
agrees to pay to B.Braun, on demand, all costs and expenses (including
reasonable attorneys' fees and costs) which may be incurred in the enforcement
of the Guarantor's liability hereunder. Payment in full of any obligation of
Curaflex under the Lease to B.Braun shall not affect the continuing liability of
the Guarantor hereunder with respect to any other obligation under the Lease
whenever arising.

         This is an unconditional and absolute guaranty and suretyship of
payment and performance, regardless of any set-off or counterclaim of Curaflex
or the Guarantor, and regardless of whether B.Braun shall have instituted any
proceeding or exhausted any rights against Curaflex, the Guarantor or any other
person to compel such performance or to collect any sum under the Lease, at law,
in equity or otherwise regardless of any other condition or contingency. B.Braun
may, in its sole discretion, enforce this Continuing Guaranty and Suretyship
("Guaranty") against either one or both of the Guarantors, each of which shall
be jointly and severally liable hereunder.

         All obligations of Curaflex to B.Braun under the Lease shall be
conclusively presumed to have been created in reliance hereupon. No invalidity,
unenforceability or release of any of Curaflex's obligations to B.Braun shall
affect this Guaranty, which shall be a primary obligation of the Guarantor.

         The Guarantor waives notice of acceptance of this Guaranty and notice
of any obligation to which it may apply, and waives presentment, demand of
payment, protest, notice of dishonor or nonpayment of any such obligation, suit
or other action by B.Braun against, and any other notice to, any party liable
thereon (including the Guarantor).

         In the event of any breach of any provision of the Lease or if Curaflex
fails to perform any other of its obligations under the Lease, or if there
occurs an event under clauses (b), (c), (d), (g) or (i) under paragraph 11 of
the Lease, B.Braun will provide written notice to Guarantor of such event and
Guarantor shall have ten (10) days to cure such breach or failure to B.Braun's
satisfaction within such ten (10) day period. If Guarantor fails to cure such
breach or failure to B.Braun's satisfaction within such period, or under any of
the following circumstances, B. Braun may, without further notice to Curaflex or
the Guarantor, declare that all obligations of Curaflex under the Lease and of
Guarantor under this Guaranty, whether or not then due, are immediately due and
payable hereunder as to the Guarantor, and B.Braun shall have the right to
enforce the obligations of the Guarantor hereunder:

1.       the failure of Guarantor to perform any of its obligations hereunder
         and, upon receiving written notice thereof from B.Braun, if Guarantor
         fails to cure such failure to B.Braun's satisfaction within ten (10)
         days after the date of such notice;

2.       a material adverse change in the financial condition of the Guarantor
         (considered collectively), or the transfer of any substantial part of
         the assets of the Guarantor (considered collectively) for a
         consideration less than the fair market value thereof; or

3.       the suspension of business of the Guarantor, or the sale, dissolution,
         merger or reorganization of the Guarantor, or the transfer of more than
         49% of the ownership interest in, or 20% of the assets of, the
         Guarantor (except to the extent that any of the foregoing occur when
         Coram Healthcare Corporation and Coram, Inc. are merged or consolidated
         into a single entity pursuant to a plan of reorganization in Bankruptcy
         Case No, 00-3329 and Bankruptcy Case No. 00-3300 (collectively, the
         "Bankruptcy Cases") and the surviving entity continues to own
         substantially all of the assets now owned by Coram Healthcare
         Corporation and Coram, Inc.).

                                       1
<PAGE>

         Guarantor hereby agrees that the automatic stay under 11 U.S.C. Section
362 shall not be applicable to the enforcement by B.Braun of any of its rights
under the terms of this Guaranty or applicable law, and the Order approving this
Guaranty will so provide.

         The Guarantor agrees that the obligations under this Guaranty shall not
be discharged under the terms of the United States Bankruptcy Code and agree to
oppose any effort to effect such outcome, unless all obligations presently due
and which may become due in the future under the Lease are fully satisfied prior
to such discharge. In the event of a plan of reorganization of the estates of
the Guarantor pursuant to which substantially all of their assets are merged or
consolidated into a single entity, the obligations under the Guaranty shall be
assumed by such reorganized entity. Notwithstanding the foregoing, in the event
a discharge of Guarantor's obligations under this Guaranty occurs, then all
currently due and future obligations under the Lease shall become immediately
due and payable by the Guarantor and shall be deemed to be an allowed
administrative claim against the Guarantor's bankruptcy estates pursuant to
Section 503 of the United States Bankruptcy Code, 11 U.S.C Section 503(b), and
shall be immediately due and payable upon demand. Any claim arising under this
Guaranty during the pendency of the Guarantor's bankruptcy proceeding shall be
deemed to be an allowed administrative claim under Section 503 (b) of the United
States Bankruptcy Code, 11 U.S.C. Section 503 (b).

         B.BRAUN WILL ONLY HAVE THE RIGHT TO EXERCISE THE FOLLOWING CONFESSION
OF JUDGMENT AFTER CONFIRMATION OF A PLAN OF REORGANIZATION OF THE BANKRUPTCY
CASES.

         AFTER THE OCCURRENCE OF AND DURING THE CONTINUANCE OF AN EVENT OF
DEFAULT UNDER THE LEASE OR A DEFAULT HEREUNDER, THE GUARANTOR HEREBY AUTHORIZES
B.BRAUN, BY ITS ATTORNEY, TO APPEAR FOR THE UNDERSIGNED AND CONFESS JUDGEMENT
AGAINST IT IN FAVOR OF B. BRAUN FOR THE FULL AMOUNT OF THE OBLIGATIONS
GUARANTEED HEREUNDER, PLUS REASONABLE ATTORNEYS FEES, WITH OR WITHOUT
DECLARATION, AND WITHOUT STAY OF EXECUTION, FOR WHICH THIS GUARANTY OR A COPY
VERIFIED BY B.BRAUN'S AFFIDAVIT SHALL BE A SUFFICIENT WARRANT. THIS AUTHORITY
SHALL CONTINUE AND MAY BE EXERCISED AS OFTEN AS B.BRAUN DESIRES FROM TIME TO
TIME UNTIL THE OBLIGATIONS ARE FULLY PAID.

         THE FOREGOING PARAGRAPH SETS FORTH A WARRANT OF ATTORNEY TO CONFESS
JUDGEMENT AGAINST THE GUARANTOR. IN GRANTING THIS WARRANT OF ATTORNEY TO CONFESS
JUDGEMENT, THE GUARANTOR ACKNOWLEDGES THAT IT UNDERSTANDS THE MEANING AND EFFECT
OF THE CONFESSION CONTAINED IN THE FOREGOING PARAGRAPH. SPECIFICALLY, THE
GUARANTOR UNDERSTANDS THAT (1) IT IS RELINQUISHING ITS CONSTITUTIONAL RIGHT TO
HAVE NOTICE AND AN OPPORTUNITY TO BE HEARD, AND THE RIGHT OT HAVE THE BURDEN OF
PROOF OF DEFAULT REST ON B.BRAUN PRIOR TO THE ENTRY OF JUDGEMENT, (2) THE ENTRY
OF JUDGEMENT MAY RESULT IN A LIEN ON ITS PROPERTY, INCLUDING ITS REAL ESTATE,
(3) IT WILL BEAR THE BURDEN AND EXPENSE OF ATTACKING THE JUDGEMENT AND
CHALLENGING EXECUTION OF THE LIEN AND SALE OF THE PROPERTY COVERED THEREBY, AND
(4) ITS PROPERTY MAY BE TAKEN TO PAY THE PRINCIPAL AMOUNT, INTEREST, COSTS AND
ATTORNEYS' FEES. ON THE ADVICE OF SEPARATE COUNSEL OF THE GUARANTOR, THE
GUARANTOR KNOWINGLY, INTENTIONALLY AND VOLUNTARILY, UNCONDITIONALLY WAIVES ITS
CONSTITUTIONAL RIGHTS AS PROVIDED HEREIN.

         Any notice or other communication required or which may be given
hereunder shall be in writing and either be delivered personally (by hand,
messenger or other overnight courier service), or deposited in the United States
mail, first class, certified, return receipt requested, postage prepaid, and
shall be deemed given (i) when delivered, if delivered personally, (ii) one
business day if delivered by overnight courier service, or (iii) three (3)
business days after the date of deposit in the United States mail, if mailed;
and shall be addressed as follows:

                                       2
<PAGE>

If to B.Braun:                               If to Guarantor:
     B. Braun Medical Inc.                        Coram Healthcare Corporation
                                                    and/or Coram, Inc.
     824 Twelfth Avenue                           1675 Broadway, Suite 900
     Bethlehem, PA 18018                          Denver, CO 80202
     Attn: Scott Quilty                           Attn: Michael Dell, Esq.
     With a copy to: Cathy Codrea, Esq.,
                     Asst. General Counsel

Either party may change its address to which notices or other communications are
to be sent by giving written notice of any such change to the other party in the
manner provided herein for giving notice. All notices sent to Guarantor
hereunder, if occurring prior to the confirmation of a Plan of Reorganization in
Bankruptcy Case 00-3329, shall also be sent to: Schnader Harrison Segal & Lewis
LLP, Suite 3600, 1600 Market Street, Philadelphia, PA 19103-7286, Attention: H.
Lee Schwartzberg, Jr., Esquire, by facsimile at (215) 972-7472.

         This Guaranty shall inure to the benefit of B.Braun and its successors
and assigns and shall be binding upon the Guarantor and the Guarantor's
successors and assigns.

         B.Braun may change the manner or terms of payment, or extend the time
for payment, of any or all of Curaflex's liabilities, and may sell, exchange,
release or surrender, or otherwise deal with in any manner or order, any other
guaranty or suretyship of, and any property by whomsoever at any time pledged to
secure, any of Curaflex's liabilities, and may exercise or refrain from
exercising any right against Curaflex or any other person in B.Braun's absolute
discretion, without affecting this Guaranty.

         The Guarantor hereby submits to the jurisdiction and venue of the Court
of Common Pleas of Lehigh County, Pennsylvania (following confirmation of a plan
of reorganization in the Bankruptcy Cases)and the United States District Court
for the Eastern District of Pennsylvania, and hereby waives trial by jury. This
Guaranty shall be construed in accordance with and enforced under the laws of
the Commonwealth of Pennsylvania, notwithstanding its laws of conflict of laws.

         Any provisions hereof that is void or unenforceable shall be
disregarded and the remaining provisions hereof shall be enforced as if such
void or unenforceable provisions were omitted.

         IN WITNESS WHEREOF, and intending to be legally bound hereby, the
undersigned has executed this Guaranty this 12th day of May, 2003.

                                          Guarantors:

                                          Coram Healthcare Corporation

                                          By /s/ Frank Geiger
                                             -------------------------
                                             Name: Frank Geiger
                                             Title: Senior Vice President,
                                                    Materials Management

                                          Coram, Inc.

                                          By /s/ Frank Geiger
                                             -------------------------
                                             Name: Frank Geiger
                                             Title: Senior Vice President,
                                                    Materials Management

                                       3<PAGE>
                                                                      (REDACTED)

                                                                    EXHIBIT 10.6

                                   MCGAW, INC.
                                       AND
                           CORAM HEALTHCARE AGREEMENT

The following Agreement has been mutually agreed upon by McGaw, a Delaware
corporation located at 2525 McGaw Avenue, Irvine, California 92714 (hereinafter
"McGaw") and Coram Healthcare Corporation located at 1125 17th Street, Denver,
Colorado 80202 (hereinafter "Customer").

WHEREAS, McGaw desires to sell certain Products and Customer desires to purchase
said Products in connection with the alternate site infusion therapy business
conducted by the Customer's subsidiaries.

NOW THEREFORE, the parties agree as follows:

PRODUCT CATEGORIES

Customer agrees to purchase the Products ("Products") detailed in Exhibit I
(Coram Healthcare Confidential Net Price List) and further agrees that McGaw
will be its primary source of supply for said Products and for all Products in
the following categories as defined by Coram's December 14, 1994 request for
proposal during the term herein. "Primary source" shall be defined as
         ) of the annual unit volume usage from each of the identified product
categories.

Amino Acids                                   Dextrose Components
I.V. Solutions                                I.V. Administration Sets (Gravity)
Mini Bags                                     Gravity Mixing Bags
I.V. Fat                                      Irrigation Solutions
TPN Compounding Equipment and Mixing Bags

EXCLUSIVE USE

Customer agrees that all items purchased under this Agreement shall be for the
exclusive use of its owned facilities or for its patients.

CONTRACT PERIOD

This Agreement covers a sixty three (63) month period and shall commence
December 1, 1995 and end February 28, 2001. This Agreement supersedes any and
all other Agreements governing the subject matter herein executed prior to the
aforementioned effective date.

PRICE PROTECTION

Pricing will be held firm through the first three (3) contract years (December
1, 1995 to November 30, 1998). Price increases for the fourth (4th) contract
year (December 1, 1998 to November 30, 1999) and the remaining fifteen (15)
month period (December 1, 1999 to February 28, 2001) shall be limited to a
maximum two and one half percent (2.5%) or the CPI, whichever is lower. Should
Customer's purchases of disposable Products exceed

                                        ), Customer shall receive no price
increase for the fourth (4th) contract year. Should Customer's purchase of
disposable Products exceed          dollars during fourth (4th) contract year
(December

                                        1                      November 17, 1995
                       Confidential - Company Proprietary

<PAGE>
                                                                      (REDACTED)

1, 1998 to November 30, 1999), Customer shall receive no price increase for the
remaining fifteen (15) month period.

MINIMUM COMMITMENT

Customer shall purchase a minimum of                                    dollars
of the product during the first year of the Agreement and                dollars
for each year thereafter (the "Minimum Committed Dollar Volume") unless
Customer's failure to purchase the Minimum Committed Dollar Volume is due to
McGaw's failure to supply Customer's orders for any reason including "Force
Majeure" set out below. For purposes of this Agreement "purchases" shall mean
the net invoice price for each product ordered and invoiced less any returns or
credits.

TERMINATION

Customer shall have the right to terminate this Agreement after sixty (60) days
written notice if McGaw fails to provide Products or service of a quality or
technical level which fail to meet ordinary standards of medical care industry.
Should Customer or any acquirer, or other successor in interest, of Customer
intend to terminate this Agreement for any other reason, Customer shall give to
McGaw a six (6) month written notice of such intent. In such event, Customer
shall reimburse McGaw the                           prorated over the remaining
term of this Agreement at a rate of                   dollars per uncompleted
quarter plus a lump sum early termination penalty to be paid within sixty (60)
days of the early termination date in accordance with the following matrix:

<Table>
<Caption>

                     EARLY
                TERMINATION DATE                PENALTY
             --------------------               -------
<S>                                             <C>
             12/1/95 to 11/30/96
             12/1/96 to 11/30/97
             12/1/97 to 11/30/98
             12/1/98 to 11/30/99
             12/1/99 to 02/28/01
</Table>

McGaw shall have the right to terminate this Agreement if Customer fails to meet
McGaw's published payment terms.

NEW BRANCH PHARMACIES

Pricing offered under this contract shall be exclusive to Customer and
Customer's branch pharmacies in effect as of the effective date of this
Agreement. Customer shall notify McGaw of its intent to add a new branch
pharmacy to this contract before such branch pharmacy will be entitled to
purchase pursuant to the terms and conditions of this Agreement.

FORCE MAJEURE

McGaw shall be excused from any delay in, or impossibility of, performance due
to any cause beyond its or its supplier's or subcontractor's control, including
but not limited to, acts of God, war, acts of government, acts of purchaser,
priorities or allocations, raw material shortages, energy or fuel shortages,
fire, flood, strike or labor trouble, sabotage, or delay in obtaining labor,
materials, equipment, or transportation. Customer agrees that McGaw may allocate
its Products among all purchasers as it deems appropriate, without liability.

                                        2                      November 17, 1995
                       Confidential - Company Proprietary

<PAGE>
                                                                      (REDACTED)

DELIVERY

Shipments will be made by McGaw to Customer FOB destination. Shipments and
billings of Customer's patients will be the sole responsibility of the Customer.

PAYMENT/TERMS

Invoice terms are Net 90 days during the first fifteen (15) months, Net 45 days
during the next twelve (12) months, and Net 30 days during to remaining
thirty-six (36) months of the Agreement. If the conversion process is not
completed within the first ninety (90) days of this Agreement, the ninety (90)
day Net term period will be adjusted by mutual agreement.

Pricing, minimum order quantities, shipping policies, returns, warranty and
damage or loss in transit policies will be in effect as outlined in the current
McGaw published General Ordering Information Policies attached hereto as Exhibit
II and as amended by McGaw from time to time. Any applicable sales, use,
privilege, excise, personal property or other taxes imposed or levied in
connection with this Agreement, whether federal, state or local shall be
separately stated in McGaw's invoice and shall be paid by Customer in addition
to the prices quoted in Exhibit I. Orders and billings shall be as set forth
hereunder.

MINIMUM ORDERS

Orders under $200 per invoice will be subject to a $40 service charge.

RETURN GOODS POLICY

Refer to Exhibit II.

SPECIAL INCENTIVES

McGaw will pay an annual                                    ) compliance rebate.
Compliance will be measured by branch and defined as                           )
The compliance rebate will be paid in the form of a credit memorandum within
sixty (60) days of the close of the first fifteen (15) month period and each
twelve (12) month contract period thereafter.

MEET THE MARKET CLAUSE

MOST FAVORED NATIONS CLAUSE

McGaw extends a commitment to Customer under which McGaw guarantees its lowest
net aggregate pricing based upon product mix.

Prices will be compared on a total contract basis (prices applied to actual
usage figures for all products) rather than a line item basis.

                                        3                      November 17, 1995
                       Confidential - Company Proprietary

<PAGE>
                                                                      (REDACTED)

RENEGOTIATION OPTION

Should Customer purchase twenty one million ($21,000,000) dollars covered in the
nine (9) Product Categories annually,                                additional
discounts shall be negotiated in good faith. This additional discount

COMPARABLE ITEMS

In the event of a backorder, McGaw reserves the right to substitute mutually
agreeable equivalent Products. Substitute Products may be delivered only with
prior approval of Customer. Substitute Products will be priced equal to or lower
than contracted prices for the items backordered. In the event McGaw cannot
provide a substitute product, Customer may purchase the product(s) from other
sources and charge McGaw for any cost of purchase in excess of the contracted
price for the period of time said Product(s) are on backorder. However, McGaw
shall have the right to drop said backordered Product from this Agreement upon
30 days notice to Customer, and no further reimbursement for the excess cost
will be due. Should McGaw stop manufacturing a Product, Customer shall not have
the right to remove the entire product category from the agreement if other
mutually acceptable McGaw Products are available.

PRODUCT SHIFT

Customer shall have the right to, at its own discretion, shift usage to other
Products that it deems more clinically or financially acceptable due to
technological changes or changes in payers reimbursement providing the shift in
product use represents a transfer in unit usage to other McGaw Products if
available and previously presented to Customer.

CONVERSION PROCESS

McGaw agrees to issue                                 to Customer covering the
cost (calculated from Exhibit I) of all competitive inventory (identified within
the nine (9) designated Product Categories) remaining in Customer's pharmacies
providing said pharmacies make determined and conscientious best efforts to
maximize the utilization of all remaining competitive inventory during the sixty
(60) day conversion period.

McGaw will pay to Customer a                      dollar
within sixty (60) days of the commencement of the term hereof. Customer agrees
to have commenced the IV. system conversion to the nine (9) Product Categories
set out above by that time. The Conversion Implementation Incentive will be paid
in the form of a credit memorandum.

HIGH SPEED COMPOUNDING EQUIPMENT

Customer agrees to use McGaw mixing bags, with the exception of dual chamber
mixing bags, exclusively on all Auto-Mix devices. Customer agrees to replace all
Auto-Mix units with a HyperFormer(R) System by November 30, 1996. A McGaw
HyperFormer System shall be made available, at no charge, to each Customer
pharmacy purchasing a minimum of two thousand (2,000) mixing bags annually per
compounding unit.

                                        4                      November 17, 1995
                       Confidential - Company Proprietary

<PAGE>
                                                                      (REDACTED)

COST DIFFERENTIAL ADJUSTMENT

During the first contract year, McGaw will reimburse Customer up to a maximum of
                                 dollars for any cost difference incurred in the
acquisition of competitive mini-bag inventory and Auto-Mix(TM) Administration
Sets. Should Customer not utilize the entire                            dollars
cost differential adjustment, the unspent balance will be divided equally
between Customer and McGaw.

TRADEMARKS AND TRADE NAMES

Customer may not change, mutilate, obscure, remove or deface Trademarks, Trade
Names or Labels appearing on any McGaw Product

COMPLIANCE WITH LAWS

Customer will comply with all Federal and State dispensing Laws and regulations
and will, upon McGaw's request, certify that its procedures with respect to any
home care patient are in full compliance with such laws and regulations.

ADDITIONAL ITEMS

Customer will provide McGaw the opportunity to evaluate SafeLine(TM) and/or
Clave(TM) needle free Products, Sigma pumps, and the Stratus(TM) Ambulatory
Infusion System prior to a decision by Customer to purchase any of these
Products during the term of this contract. Providing these Products meet
Customer's clinical standards and financial requirements, McGaw will be awarded
the business under a new product category with compliance outlined under Product
Categories.

ENTIRE AGREEMENT

The Agreement and attached Exhibits I and II are the entire Agreement between
the parties hereto, there being no prior written or oral promises or
representations not incorporated herein.

APPLICABLE LAW

This Agreement shall be governed by the laws of the State of California
excluding any choice of law rules which may direct the application of the laws
or any other jurisdiction.

AMENDMENTS

No amendment or modification of the terms of this Agreement shall be binding on
either party unless reduced to writing and signed by an authorized
representative of the party to be bound.

ASSIGNMENT

This Agreement shall be binding upon and inure to the benefit of the parties
hereto, their respective heirs, permitted successors and assigns. This Agreement
may not be assigned, transferred or in any way disposed of by Customer without
the prior written consent of McGaw, which consent shall not be unreasonably
withheld.

SEVERABILITY

Each provision of this Agreement shall be valid and enforced to the fullest
extent permitted by law. The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of any other
provision.

                                        5                      November 17, 1995
                       Confidential - Company Proprietary

<PAGE>
                                                                      (REDACTED)

NO AGENCY

The relationship between McGaw and Customer established by this Agreement is
solely that of a seller and buyer, and neither party is in any way the legal
representative or agent of the other. Neither party is authorized or empowered
to assume any obligation of any kind, implied or expressed, on behalf of the
other party, without the express written consent of the other.

INDEMNIFICATION

The parties hereby acknowledge and agree that the Customer is a party to various
agreements with the suppliers of the products and supplies needed to operate its
business and that the relationship contemplated by this Agreement was offered by
McGaw pursuant to a request for proposal submitted by the Customer. Because the
performance of this Agreement by the Customer may cause the Customer to change
its current purchasing patterns, which Customer represents it has the right to
do, the Customer hereby agrees to indemnify and hold McGaw harmless from and
against any claims that may be made against McGaw arising out of the Customer's
execution, delivery or performance of this Agreement, whether such claims arise
out of Contract of Tort. In the event that such claims shall arise, McGaw shall
notify the Customer, and the Customer shall have the right to choose the
Attorneys representing McGaw. Additionally, Customer shall have the right to
control the defense, settlement and resolution of such claims.

COUNTERPARTS

For the convenience of the parties hereto, this Agreement may be executed in one
or more counterparts, each of which shall be deemed an original for all
purposes.

AGREED AND ACCEPTED,

CORAM HEALTHCARE CORPORATION             McGAW INC.
THIS 17th DAY OF NOVEMBER 1995           THIS 17th DAY OF NOVEMBER 1995

/s/ JOSEPH H. BANE                       /s/ ROBERT F. THORNHILL
----------------------------             ----------------------------------
(Signature)                              (Vice President, Corporate Accounts)

Joseph H. Bane                                    11/17/95
----------------------------             ----------------------------------
(Typewritten Name/Title)                 (Date)

         11/17/95                        /s/ WILLIAM C. WARNER
----------------------------             ----------------------------------
(Date)                                   (Manager, Corporate Accounts)

                                                  11/21/95
                                         ----------------------------------
                                         (Date)

                                        6                      November 17, 1995
                       Confidential - Company Proprietary
<PAGE>
                                   EXHIBIT II

================================================================================
GENERAL ORDERING INFORMATION
================================================================================

PRICING POLICY: Terms, conditions, or pricing on customer's purchase orders
deviating from McGaw Inc. terms, conditions, and pricing will not be honored
unless prior commitment is made by McGaw in Irvine, California. All pricing
quotes must be documented, signed by a McGaw representative and are not valid
unless approved by McGaw Sales/Marketing Executive Offices in Irvine,
California. The prices shown in this price list refer to full case quantities.
Prices do not include state or local tax. Taxes will be added where applicable
unless appropriate proof of tax exemption is provided.

VOLUME DISCOUNTS: Discounts from List Prices are normally given in consideration
of volume usage. Volume discounts quoted are subject to acceptance by our
Executive Offices in Irvine, California and must be in writing. Acceptance shall
be only by letter or Agreement.

PRICING SOLICITATIONS: Send all pricing solicitations for products in this
catalog to Attn: Bids Department, McGaw Inc., P.O Box 19791, Irvine, California
92713-9791.

TERMS OF SALE: Payment terms are those as stated on our invoices.

DISCOUNTS: If discount terms apply, discounts should be taken at the time of
payment. Requests for discounts not taken at the time of payment will be limited
to six months from the date of payment. Discounts will not be reimbursed if
request is received after six months from date of payment or if payment received
after discount due date.

INVOICE BILLINGS:

1.   Any disputed amounts may be withheld until resolved. THE BALANCE OF THE
     INVOICE, NOT IN DISPUTE, MUST BE REMITTED PER TERMS. Cash discounts will be
     allowed only on that portion of the invoice that is paid within the normal
     discount period.

2.   The disputed item for deduction should be explained by forwarding
     information with remittance or documentation mailed to Attn: Customer
     Service Department, McGaw, Inc., PO Box 19791, Irvine, CA 92713-9791. In
     the case of shortage, damage, breakage etc., a copy of the carrier delivery
     receipt noting the exception, must be forwarded for prompt credit
     adjustment.

3.   Balances remaining unpaid at due date are subject to a service charge of
     1 1/3% per month or the highest rate permitted by law, whichever is lower,
     until paid. Any discounts or credits will be applied against delinquent
     balances before reimbursement is made. If payments become more than sixty
     (60) days in arrears, supplier shall have the right to cancel the agreement
     at its sole discretion.

TAX INFORMATION: Resale/exemption certificates are required in order to be
exempt from applicable taxes. Tax adjustments will be limited to sixty (60) days
after invoice date. Call the Tax Department for further information at (800)
624-2927.

MINIMUM ORDER QUANTITY: All products must be ordered in full case quantities.
Orders received with a value of less than $200.00 will be subject to a handling
charge of $40.00. (Pharmaceutical products excluded.)

RETURNED GOODS POLICY: Product returns are subject to the following conditions.

1.   All items ORDERED IN ERROR, SHIPPED IN ERROR or deemed by the McGaw
     Representative as EXCESS STOCK may be considered for return.

2.   Items ORDERED or SHIPPED IN ERROR may be returned to the local shipping
     warehouse provided customer service is notified and the products are
     returned within thirty (30) days. Items ORDERED IN ERROR must be returned
     freight prepaid by the customer. Call Customer Service to arrange for the
     return of the merchandise (800) 624-2946.

3.   Before returning EXCESS STOCK, authorization must be issued by a McGaw
     Sales Representative. A Returned Goods Authorization Form (RGA) must be
     completed. The form requires lot numbers, quantities and catalog numbers
     along with a specific reason for return. Only items appearing on an
     approved RGA form are acceptable for return. UNAUTHORIZED RETURNS WILL BE
     DESTROYED and no credit issued.

4.   All EXCESS STOCK returned goods must be shipped Freight Prepaid to McGaw,
     Inc., 2525 McGaw Avenue, Irvine, CA 92714-5895.

5.   All returns are subject to a 25% HANDLING/RESTOCKING CHARGE. Items shipped
     in error must be returned within thirty (30) days from receipt and will be
     exempt from this charge.

6.   Credit will be issued for all returns provided.

     a.   Products have at least one year shelf-life remaining or products with
          original expiration dating of eighteen months or less have at least
          six months shelf-life remaining.

     b.   Proper authorization has been obtained.

     c.   Cartons resealed by customer are not eligible to return.

     d.   Products are current inventory items.

     e.   Merchandise has been shipped and billed to the customer by McGaw.

7.   Certain products ARE NOT ELIGIBLE for return. These are:

     a.   Products which have deteriorated because of improper handling, abuse
          or other factors beyond the control of McGaw.

     b.   Products which have been opened, partly used or which the labels or
          seals have been removed or tampered.

     c.   Products which have been involved in a special promotion sale.

     d.   Broken, damaged or opened cases.

     e.   Special products made to the customer's specification.

     f.   Sets or devices over three (3) years old.

8.   Except where a McGaw error exists, transportation on all products returned
     for credit must be PREPAID BY THE CUSTOMER.

9.   Products which are to be returned for repair (e.g medical device equipment)
     must be accompanied by an approved Returned Goods Authorization (RGA) which
     clearly states the reason for return.

EXPIRATION DATE: On dated products, the expiration date is shown as a month and
year, e.g. 8/95. The date of expiration is the last day of the given month
e.g., August 31, 1995.

WARRANTY: All McGaw products are warranted to meet all requirements of all
applicable federal laws and regulations. No warranty of any kind goes beyond the
description of the products listed in this catalog, including any supplement
thereto, and any directions for use in their labeling. Unless these products are
used in accordance with the directions in the labeling, any and all warranties,
expressed or implied, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS, are
specifically denied.

SHIPPING:

1.   FREIGHT CHARGES will be prepaid when orders are shipped via a
     transportation mode and carrier selected by McGaw. Unless otherwise stated
     in an agreement, shipment of biomedical Intelligent Devices and
     disposables will be made F.O.B Origin.

2.   When EXPEDITED TRANSPORTATION, SPECIALIZED SERVICE, OR ALTERNATE
     TRANSPORTATION MODES are specified, or requests made are inconsistent with
     efficient distribution practices, an additional charge to cover the
     premium expense will be added to the invoice.

3.   INSIDE DELIVERIES OR MULTIPLE DELIVERIES are subject to additional charges
     based on current common carrier rates or hourly rates.

4.   PALLETIZED DELIVERIES will be encouraged. Customers receiving this service
     will be required to exchange on a one-for-one basis a pallet of the same
     condition and specification at the time of each delivery, or accept an
     invoice for value of unreturned pallets.

5.   Scheduled shipments can be established from your McGaw Distribution Center.
     Contact your McGaw Sales Representative to be set up on the scheduled
     shipment program.

PROOF OF DELIVERY: McGaw will provide proof of delivery as follows:

1.   Proof of delivery request will be subject to a $35.00 service charge. This
     fee will be charged whenever a valid proof of delivery is obtained to
     offset our administrative costs.

DAMAGED OF LOSS IN TRANSIT: Identity of items and extent of damage or loss must
be noted on customer's copy of delivery document by agent of the transportation
company if damage is discovered after receipt of shipment, notify the
transportation company immediately and request that inspection be made and an
inspection report rendered. McGaw will be happy to issue a credit for the loss
or damage and file a claim with the carrier, providing your request is promptly
forwarded to the Irvine office and received WITHIN TEN (10) DAYS. This claim
request must be accompanied by a delivery receipt or an inspection report upon
which the transportation company has properly noted such damage or loss.

SEND COPY OF CARRIER FREIGHT BILL TO IRVINE, CALIFORNIA INDICATING ITEM AND
QUANTITY DAMAGED OR NOT RECEIVED.

COUNT AND INSPECT YOUR FREIGHT BEFORE CARRIER DEPARTS.

DAMAGED MERCHANDISE SHOULD NOT BE ACCEPTED.

PLEASE FORWARD ALL INFORMATION TO ATTN: CUSTOMER SERVICE DEPARTMENT,
MCGAW, INC., P.O. BOX 19791, IRVINE, CA 92713-9791.

CONDITIONS OF SALE: McGaw shall be excused from any delay in, or impossibility
of performance due to any cause beyond its or its supplier's or subcontractor's
control, including, but not limited to, acts of God, war, acts of government,
acts of purchase priorities or allocations, raw material shortages, fire, flood,
strike or labor trouble, sabotage or delay in obtaining labor, materials,
equipment, or transportation.

FOR ORDER PLACEMENT: We welcome orders either by telephone, electronically,
mail, or by fax. For telephone orders, please call (800)624-2948. For fax orders
please dial (714) 660-3001. NOTE: Hawaii customers should call (800)836-7570
first.

For further information regarding electronic ordering, please call
Customer Systems at (800) 441-7828.

All mail orders should be directed to Attn. Customer Service Department,
McGaw, Inc., P.O Box 19791, Irvine, CA 92713-9791.

McGaw Product Catalog           February 1, 1995                       3
<PAGE>

REPORT NO. M81160-01              MCGAW, INC.                  03/26/97 09:35:25

                      * CONFIDENTIAL CONTRACT PRICE LIST *

                            PRICING AS OF: 03/26/97

                                CORAM HEALTHCARE

                           DENVER            CO 80202

                                  GROUP: G127

                                                                        REDACTED
<PAGE>
                                                                      (REDACTED)

February 6, 1996                                                (STAMP)

                               (MCGAW LETTERHEAD)

Joseph H. Bane
Vice President, Materials Management
Coram Healthcare
1125 Seventeeth Street, Suite 1500
Denver, CO 80202

Dear Joe:

Please consider this letter as an addendum to current Coram Healthcare
Agreement with McGaw commencing December 1, 1995.

McGaw is pleased to add and/or modify pricing on the following catalog numbers:

<Table>
<Caption>

Catalog No.    Description                       Units/cs Price each  Price case
-----------    ------------                      -------- ----------  ----------
<S>            <C>                               <C>                  <C>
V1712          Low Pressure Trimed filer (0.22u),
               Control Clamp, two slide clamps,
               injection site 6" and 84" above
               distal end, two piece male luer
               lock

V1423          Control clamp, injection sites 6"
               and 80" above distal end, slide
               clamp, 2 piece male luer lock

V1482          Control clamp, injection site 26"
               above distal end, 2 piece male
               luer lock 106"

V1422          Vented spike, Control clamp,
               injection sites 6" and 28" above
               distal end, 2 piece male luer lk

V1426          Control clamp, injection sites 6"
               and 28" above distal end, 2 piece
               male luer lock 106"

V1785          Check valve, injection sites 6",
               28" and 82" above distal end, Low
               pressure Trimed Filter (0.22u),
               Control clamp, slide clamp, two
               piece male luer lock 108"

V1447          Check valve, injection sites 6:,
               28" and 90" above distal end,
               Control clamp slide clamp, two
               piece male luer lock 115"

V6203          Microbore 36" extension set with
               PVC free fluid path. Use with
               higher flow rates and viscous
               fluids, 0.03" ID, male and female
               luer locks. Priming volume: 0.5mL
               36"
</Table>
<PAGE>
                                                                      (REDACTED)
                               (MCGAW LETTERHEAD)

<Table>
<Caption>
Catalog No.   Description                             Units/cs    Price each    Price case
-----------   -----------                             --------    ----------    ----------
<S>           <C>                                     <C>         <C>           <C>

V6213         Microbore 60" extension set with PVC
              free fluid path. Use with higher flow
              rates and viscous fluids. 0.03" ID,
              male and Female luer locks. Priming
              Volume:0.8L 60"

V5450         Microbore extension set, 31 in, male
              llk at each end, slide clamp prime
              volume 0.7mL

V5456         Microbore extension set, 63 in, male
              llk at each end, slide clamp prime
              volume 1.3mL

V2511         Y-Type, drip chamber with (170u) blood
              filter, two roller clamps, Control
              clamp, injection site 6" above distal
              end, two piece male llk 98".

V1488         Check valve, injection sites 6", 28"
              and 90" above distal end, Control
              clamp, slide clamp, two piece male
              llk 115"
</Table>

All other terms and conditions shall be in accordance with your existing
contract with McGaw, including any subsequent addenda.

Thank you for your continued use of McGaw products. We would appreciate your
signing and returning one copy of this letter in the stamped, self-addressed
envelope, which is enclosed. Should you have any questions regarding this
addendum, please contact our Denver National Accounts office at (303) 220-7111.

Very truly yours,                             Accepted by:

/s/ WILLIAM C. WARNER                         /s/ JOSEPH H. BANE
                                              ---------------------------------
William C. Warner                             (Authorized Signature)
Manager, Corporate Accounts
                                              Joseph H. Bane
                                              ---------------------------------
                                              (Printed or Typed name and Title)

                                              2/28/96
                                              ---------------------------------
                                              (Date)
<PAGE>
                                                                      (REDACTED)

                                                                         (STAMP)

February 14, 1996

                               (MCGAW LETTERHEAD)

Joseph H. Bane
Vice President, Materials Management
Coram Healthcare
1125 Seventeeth Street, Suite 1500
Denver, CO 80202

Dear Joe:

Please consider this letter as an addendum to current Coram Healthcare
Agreement with McGaw commencing December 1, 1995.

McGaw is please to add and/or modify pricing on the following catalog numbers:

<Table>
<Caption>
Catalog No.  Description                                 Units/cs  Price each  Price case
-----------  -----------                                 --------  ----------  ----------
<S>          <C>                                         <C>       <C>         <C>
V6400        Basic IV Administration Set macro-drop (15
             drops/mL). Control(TM) clamp, 1 injection
             site, male luer lock 101"

V6405        Basic IV Administration Set Macro drop (15
             drops/mL). Control clamp, 1 injection
             site, male luer lock 101"

V6410        Additive IV Administration Set Macro-drop
             (15 drops/mL), Check valve Control clamp,
             slide clamp, 3 injection sites, male luer
             lock 113"

V6413        Additive IV Administration Set Macro-drop
             check valve, Control clamp, 3 injection
             sites, male luer lock 113"

V6415        Additive IV Administration Set Mini-drop
             (60 drops/mL), check valve, Control clamp,
             3 injection sites, male luer lock 99"

V6420        Metriset(R) Solution Administration Set 150
             mL mini-drop (60 drops/mL), buret, Control
             clamp, 1 injection site, male luer lock 97"

V6430        Filtered Additive IV Administration Set
             Macro-drop (15 drops/ml), check valve,
             .22u Trimed(TM) filter, Control clamp,
             2 injection sites, slide clamp, male luer
             lock 100"
</Table>
<PAGE>
                                                                      (REDACTED)

Coram Addendum
February 14, 1996                                                         Page 2

<Table>
<Caption>
Catalog No.     Description                                            Units/cs    Price each    Price case
-----------    ------------                                            --------    ----------    ----------
<S>             <C>                                                    <C>         <C>           <C>

V1402          Set for I.V. Solution Administration (15 drops/mL)
               roller clamp, two piece male luer lock 89"

V1432          Metriset Mini-Drop Sets without Automatic Shutoff
               (60 drops/mL) roller clamp, Control clamp,
               injection sites 6" and 28" above distal end, slide
               clamp two piece male luer lock 109"

V1485          ADDitIV Primary Set with check valve, injection
               sites 6" and 80" above distal end, Control clamp,
               two piece male luer lock 106"

V1739          Metriset Mini-Drop set without automatic shut off
               (60 drops/ml) Roller clamp, Control clamp,
               injection sites 6" and 82" above distal end, Low
               Pressure Trimed (filter (0.22u) slide clamp, two piece
               male luer lock.
</Table>

All other terms and conditions shall be in accordance with your existing
contract with McGaw, including any subsequent addenda.

Thank you for your continued use of McGaw products. We would appreciate your
signing and returning one copy of this letter in the stamped, self-addressed
envelope, which is enclosed. Should you have any questions regarding this
addendum, please contact our Denver National Accounts office at (303) 220-7111.

Very truly yours,                       Accepted by:

/s/ WILLIAM C. WARNER                   /s/ JOSEPH H. BANE
                                        ----------------------------------------
William C. Warner                       (Authorized Signature)
Manager, Corporate Accounts
                                        Joseph H. Bane
                                        ----------------------------------------
                                        (Printed or Typed Name and Title)

                                        2/28/96
                                        ----------------------------------------
                                        (Date)
<PAGE>
                                                                      (REDACTED)
February 26, 1996

                                                                         (STAMP)
(MCGAW LOGO)

Joseph H. Bane
Vice President, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 1500
Denver, CO  80202

Dear Joe:

Please consider this letter as an addendum to current Coram Healthcare Agreement
with McGaw commencing December 1, 1995.

McGaw is pleased to add and/or modify pricing on the following catalog numbers:

<Table>
<Caption>
Catalog No.       Description                                                    Units/cs    Price each        Price case
-----------       -----------                                                    --------    ----------        ----------
<S>               <C>                                                            <C>         <C>               <C>
V6510             Microbore Extension Set, tubing 0.023" ID, male and
                  female luer locks. Priming Volume: 0.3mL

V6516             Microbore Extension Set, tubing 0.050" ID, male and
                  female luer locks. Priming Volume: 2.5mL. Use with
                  higher flow rates and viscous fluids
</Table>

All other terms and conditions shall be in accordance with your existing
contract with McGaw, including any subsequent addenda.

Thank you for your continued use of McGaw products. We would appreciate your
signing and returning one copy of this letter in the stamped, self-addressed
envelope, which is enclosed. Should you have any questions regarding this
addendum, please contact our Denver National Accounts office at (303)220-7111.

Very truly yours,                            Accepted by:

/s/ WILLIAM C. WARNER                        /s/ JOSEPH H. BANE
                                             ---------------------------------
William C. Warner                            (Authorized Signature)
Manager, Corporate Accounts
                                             Joseph H. Bane
                                             ---------------------------------
                                             (Printed or Typed name and Title)

                                             2/29/96
                                             ---------------------------------
                                             (Date)
<PAGE>
                                                                      (REDACTED)

                                                                         (STAMP)

                               (MCGAW LETTERHEAD)

May 29, 1996

Mr. Robert F. Roose, Jr.
Vice President, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 1500
Denver, CO 80202

Dear Bob:

As discussed, this letter is an amendment to our current McGaw, Inc. and Coram
Healthcare Agreement effective December 1, 1995 through February 28, 2001,
(Agreement).

The following represents changes to the corresponding paragraphs in the above
referenced Agreement. Except as modified below, all other provisions of the
Agreement remain the same.

Product Categories

Provisions for this paragraph in the Agreement remain the same, except "Primary
Source" shall be defined as                                      from each of
the identified product categories.

Contract Period

This Agreement will now cover an eighty-seven (87) month period which started
December 1, 1995, and will end February 28, 2003.

Price Protection

The provisions of this paragraph shall be replaced with the following:

Pricing will be held firm for the first two (2) years, (December 1, 1995 to
November 30, 1997). Price increases for the third (3rd), fourth (4th), fifth
(5th) and sixth (6th) contract years, (December 1, 1997 to November 30, 2001),
and the remaining fifteen (15) month period, (December 1, 2001 to February 28,
2003), shall be limited to a maximum of two and one half percent (2.5%), or the
CPI, whichever is lower.

<PAGE>

                                                                      (REDACTED)

Mr. Robert F. Roose, Jr.
May 29, 1996                                                            (STAMP)
Page 2

Minimum Commitment

The provisions of this paragraph shall be replaced with the following:

Customer shall purchase         of the nine product categories listed in the
Product Categories paragraph and, in addition, shall purchase        of any
other product category manufactured or distributed by McGaw once Customer's
existing obligations to other sources for said products expire. This minimum
commitment shall be reviewed every three months starting no later than July
15, 1996 and Customer shall have sixty (60) days from the date of this review
to convert any products within the original nine product categories and any
additional products to McGaw. Should Customer not convert the identified
products to McGaw within sixty (60) days, a payment of
                                    shall be provided to McGaw within thirty
(30) days of notification by McGaw.

Termination

The provisions of this paragraph shall be replaced with the following:

Customer shall have the right to terminate this Agreement after sixty (60) days
written notice if McGaw provides Products or service of a quality or technical
level which fail to meet ordinary standards of medical care industry. Should
Customer or any acquirer, or other successor in interest, of Customer intend to
terminate this Agreement for any other reason, Customer shall give to McGaw a
six (6) month written notice of such intent. In such event, Customer shall
reimburse McGaw the                   referred to below, prorated over the
remaining term of this Agreement at a rate of              dollars per
uncompleted quarter plus a lump sum early termination penalty to be paid within
sixty (60) days of the early termination date in accordance with the following
matrix:

<Table>
<Caption>
                EARLY TERMINATION DATE          PENALTY
                ----------------------          -------
<S>                                             <C>
                 12/1/95 to 11/30/96

                 12/1/96 to 11/30/97

                 12/1/97 to 11/30/98

                 12/1/98 to 11/30/99

                 12/1/99 to 11/30/00

                 12/1/00 to 11/30/01

                 12/1/01 to 2/28/03
</Table>

McGaw shall have the right to terminate this Agreement if Customer fails to
meet McGaw's published payment terms.
<PAGE>
                                                                      (REDACTED)

                                                                         (STAMP)

Mr. Robert F. Roose, Jr.
May 29, 1996
Page 3

The provisions of the current paragraph shall be replaced with the following.

McGaw will pay to Customer a
       by not later than May 20, 1996 upon signature of this amendment. The
Conversion Implementation Incentive will be paid in the form of a credit
memorandum.

This entire paragraph and resulting obligation is deleted from the Agreement.

In addition to the above modifications of the Agreement, McGaw will provide
reasonable training and appropriate equipment for Coram to perform "End Product"
testing for pediatric patients in five separate Customer facilities.

Arrangements with Third Party Payers

The parties hereto acknowledge and agree that Coram conducts its operations
through its duly licensed subsidiaries and that this Amendment is being entered
into for the benefit of such entities. Coram's operations include the delivery
of pharmaceutical products and services to patients pursuant to arrangements
with third party payers, including insurance companies, health maintenance
organizations, preferred provider organizations, Medicare and certain state
Medicaid programs; hospitals; home health agencies and physicians. For purposes
of this Amendment, all products distributed by Coram under these types of
arrangements shall be considered to be the "exclusive use" of Coram.

With our signature below, this amendment will become part of our existing
Agreement.

Best regards,                                  ACCEPTED BY:

                                               /s/ ROBERT F. ROOSE, JR.
/s/ ROB THORNHILL                              ---------------------------------
                                               (Authorized Signature)
Rob Thornhill
Vice President, Corporate Accounts                    Robert F. Roose, Jr.
                                                        Vice President
                                               ---------------------------------
                                               (Printed or Typed Name and Title)

RT:crg                                         6/3/96
                                               ---------------------------------
                                               (Date)

<PAGE>
                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

September 27, 1996

Randy Sanger
Director, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Randy:

Please consider this letter as an addendum to current Coram Healthcare Agreement
with McGaw commencing December 1, 1995.

McGaw is pleased to add and/or modify pricing on the following catalog numbers:

<Table>
<Caption>

CATALOG                                                UNITS           PRICE
NUMBER        DESCRIPTION                              CASE       EACH      CASE
<S>           <C>                                      <C>       <C>        <C>
V5410         Extension Set, 6 inches, Microbore
              tubing, slide clamp, luer lock
</Table>

All other terms and conditions shall be in accordance with your existing
contract with McGaw, including any subsequent addenda.

Thank you for your continued use of McGaw products. We would appreciate your
signing and returning one copy of this letter in the stamped, self-addressed
envelope, which is enclosed. Should you have any questions regarding this
addendum, please contact our Denver National Accounts office at (303) 220-7111.

Very truly yours,                              Accepted by:

/s/ WILLIAM C. WARNER                          /s/ RANDY SANGER
                                               ---------------------------------
                                               (Authorized Signature)
William C. Warner
Manager, Corporate Accounts                    Randy Sanger
                                               ---------------------------------
                                               (Printed or Typed name and Title)

                                               9/30/96
                                               ---------------------------------
cc: Sandy Matsumota, R.Ph.                     (Date)

<PAGE>

                                                                      (REDACTED)
                               (MCGAW LETTERHEAD)

October 22, 1996

Randy Sanger
Director, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Randy:

Please consider this letter as an addendum to current Coram Healthcare Agreement
with McGaw commencing December 1, 1995.

McGaw is pleased to add and/or modify pricing on the following catalog numbers:

<Table>
<Caption>

Catalog                                                     Units  Price  Price
Number        Description                                   Case   Each   Case
------        -----------                                   -----  -----  -----
<S>           <C>                                           <C>    <C>    <C>

US 1022       Dual Cham TPN Bag HyperFormer(TM) Gravity

USB2022       Dual Cham TPN Bag HyperFormer(TM) Gravity 2L

USB3022       Dual Cham TPN Bag HyperFormer(TM) Gravity 3L
</Table>

All other terms and conditions shall be in accordance with your existing
contract with McGaw, including any subsequent addenda.

Thank you for your continued use of McGaw products. We would appreciate your
signing and returning one copy of this letter in the stamped, self-addressed
envelope, which is enclosed. Should you have any questions regarding this
addendum, please contact our Denver National Accounts office at (303) 220-7111.

Very truly yours,                            Accepted by:

/s/ WILLIAM C. WARNER                        /s/ RANDY SANGER
                                             -----------------------------------
                                             (Authorized Signature)
William C. Warner
Manager, Corporate Accounts                  Randy Sanger
                                             -----------------------------------
                                             (Printed or Typed name and Title)

cc: Sandy Matsumoto, R.Ph.                   11/8/96
                                             -----------------------------------
                                             (Date)

<PAGE>

                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

December 6, 1996

Robert F. Roose Jr.
Vice President, Materials Management
Coram Healthcare
1125 Seventeenth St., Suite 2100
Denver, CO 80208

Dear Bob:

Please consider this correspondence an addendum to and an integral part of the
current McGaw Inc. and Coram Healthcare Agreement effective December 1, 1995 and
running through February 28, 2001, and, the Agreement Addendum dated May 29,
1996, extending the Agreement Term through February 28, 2003.

McGaw agrees to supply fifty four (54) refractometer units (VWR catalog number
55680-506,                             to designated Coram pharmacies at no
charge. Ownership of all refractometer inventories will remain with McGaw.
Designated Coram pharmacies shall have unlimited use of all refractometer units
during the Agreement Term. At the conclusion of the Agreement Term, all
refractometer inventory shall be returned to McGaw or be purchased by Coram at
the price of                               dollars per each non-returned unit.
Simple straight line depreciation was used to determine residual value.

With our signatures below, this amendment will become part of our existing
Agreement.

Very truly yours,                             Accepted by:

/s/ WILLIAM C. WARNER                         /s/ RANDALL R. SANGER
                                              ----------------------------------
                                              Signature

William C. Warner                             Randy Sanger, DMM
Manager, National Accounts                    ----------------------------------
                                              Printed Name and Title

                                              12/10/96
                                              ----------------------------------
                                              Date

<PAGE>

                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

January 17, 1997

Robert F. Roose Jr.
Vice President, Materials Management
Coram Healthcare
1125 Seventeenth St., Suite 2100
Denver, CO 80208

Dear Bob:

Please consider this correspondence an addendum to and an integral part of the
current McGaw Inc. and Coram Healthcare Agreement effective December 1, 1995 and
running through February 28, 2001, and, the Agreement Addendum dated May 29,
1996, extending the Agreement Term through February 28, 2003.

McGaw agrees to supply an additional twenty six (26) refractometer units to the
fifty four (54) refractometer units currently in place (VWR catalog number
55680-506, acquisition cost $936.00 each) to designated Coram pharmacies
                            . Ownership of all refractometer inventories will
remain with McGaw. Designated Coram pharmacies shall have unlimited use of all
refractometer units during the Agreement Term. At the conclusion of the
Agreement Term, all refractometer inventory shall be returned to McGaw or be
purchased by Coram at the price of          dollars per each non-returned unit.
Simple straight line depreciation was used to determine residual value.

With our signatures below, this amendment will become part of our existing
Agreement.

Very truly yours,                                    Accepted by:

                                                     /s/ RANDY SANGER
/s/ WILLIAM C. WARNER                                ---------------------------
                                                     Signature

William C. Warner                                    Director, MM
Manager, National Accounts                           ---------------------------
                                                     Printed Name and Title

                                                     2/3/97
                                                     ---------------------------
                                                     Date

                                    (STAMP)

<PAGE>

                                                                      (REDACTED)
                               (MCGAW LETTERHEAD)

April 29, 1997

Randy Sanger
Director, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Randy:

Please consider this letter as an addendum to current Coram Healthcare Agreement
with McGaw commencing December 1, 1995.

McGaw is pleased to add and/or modify pricing on the following catalog numbers:

<Table>
<Caption>

Catalog                                            Units     Price     Price
Number       Description                           Case      Each      Case
------       -----------                           -----     -----     -----
<S>          <C>                                   <C>       <C>       <C>

V 1905       Vented Transfer Set, high speed
</Table>

All other terms and conditions shall be in accordance with your existing
contract with McGaw, including any subsequent addenda.

Thank you for your continued use of McGaw products. We would appreciate your
signing and returning one copy of this letter in the stamped, self-addressed
envelope, which is enclosed. Should you have any questions regarding this
addendum, pleas contact our Denver National Accounts office at (303) 220-7111.

Very truly yours,                            Accepted by:

/s/ WILLIAM C. WARNER                        /s/ RANDY SANGER
                                             -----------------------------------
                                             (Authorized Signature)
William C. Warner
Manager, Corporate Accounts                  Randy Sanger
                                             -----------------------------------
                                             (Printed or Typed name and Title)

cc: Sandy Matsumoto, R.Ph.                   5/2/97
                                             -----------------------------------
                                             (Date)

<PAGE>
                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

December 15, 1997

Mr. Robert F. Roose, Jr.
Vice President, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Bob:

This letter is an amendment to the current McGaw and Coram Healthcare Agreement
effective December 1, 1995, through February 28, 2001, (hereinafter referred to
as "Current Agreement") and the amendment dated May 29, 1996, extending the
Current Agreement through February 28, 2003 (hereinafter referred to as "First
Amendment").

McGaw shall pay to Customer an Agreement Extension Bonus in the amount of
                                                 within sixty days of the
initiation of this Amendment. The extension bonus will be paid in the form of a
credit memorandum.

PRODUCT CATEGORIES

All provisions of this paragraph shall remain the same as the Current Agreement
and First Amendment with the exception of the following three (3) product
categories which shall be added to the existing nine (9) product categories: (1)
needle free sets and components; (2) elastomeric infusion devices and (3)
pharmacy devices (the types of products listed on the pages of the B. Braun
Catalog sheets and attached hereto as Exhibit I).

CONTRACT PERIOD

The provisions of this paragraph in the Current Agreement and the First
Amendment shall be replaced with the following:

This agreement will now cover a one hundred eleven (111) month period which
started December 1, 1995, and will end February 28, 2005.

PRICE PROTECTION

The provisions of this paragraph in the Current Agreement and the First
Amendment shall be replaced with the following:

Pricing will be held firm for the first four (4) years, (December 1, 1995 to
November 30, 1999). Price increases for the fifth (5th), sixth (6th), seventh
(7th) and eighth (8th) Agreement years (December 1, 1999 to November 30, 2003),
and the remaining fifteen (15) month period, (December 1, 2003 to February 28,
2005), shall be limited to a maximum of two and one half percent (2.5%), or the
CPI, whichever is lower.

<PAGE>
                                                                      (REDACTED)

Mr. Robert F. Roose, Jr.
December 15, 1997
Page 2

SPECIAL INCENTIVES

The provisions of this paragraph in the Current Agreement shall be replaced with
the following:

McGaw shall pay to Customer                                    rebate
in the amount of           Compliance shall be measured by branch and defined as
                                    the available annual unit volume from the
twelve (12) product categories listed under Product Categories as stated in this
Amendment. The Compliance Rebate shall be paid in the form of a credit
memorandum within sixty (60) days of the close of each Agreement quarter. To
facilitate the product conversion process, compliance requirements covering
needle free sets and components, elastomeric devices and pharmacy devices
(B. Bran products) shall begin March 1, 1998.

Should Customer's compliance in any of the twelve (12) Product Categories become
unattainable due to a significant change in clinical procedures, or the
introduction of new technology not available from McGaw, McGaw shall excuse
Customer                            McGaw shall continue to pay to Customer the

ADDITIONAL FIRM PRICING INCENTIVES

Additional firm pricing incentives shall be awarded to Customer in accordance
with the following Agreement.

<Table>
<Caption>

  Total Agreement Year Dollar Volume Performance           Total Annual Additional Firm Pricing
<S>                                                        <C>
                                                                        One (1) year

                                                                        Two (2) years

                                                                        Three (3) years
</Table>

Additional firm Pricing incentives shall be calculated on the
                                               and shall cancel, if applicable,
a scheduled price increase or increases as per the aforementioned Price
Protection paragraph.

TERMINATION

The provisions of this paragraph in the Current Agreement and the First
Amendment shall be replaced with the following:

Customer shall have the right to terminate this Agreement after sixty (60) days
written notice if McGaw provides products or service of a quality or technical
level which fail to meet ordinary standards of the medical care industry. Should
Customer or any acquirer, or other successor in interest, of Customer intend to
terminate this Agreement for any other reason, Customer shall give to McGaw a
six (6) month written notice of such intent. In such event, Customer shall
reimburse interest, of Customer intend to terminate this Agreement for any other
reason, Customer shall reimburse McGaw the                          referred to
in the Current Agreement and

<PAGE>
                                                                      (REDACTED)

Mr. Robert F. Roose, Jr.
December 15, 1997
Page 3

modified in the First Amendment and the                              referred to
in this Amendment, both of which have been prorated over the remaining term of
this Agreement at a combined rate of                    dollars per uncompleted
quarter plus a lump sum early termination penalty to be paid within sixty (60)
days of the early termination date in accordance with the following matrix:

<Table>
<Caption>
       EARLY TERMINATION DATE          PENALTY
       ----------------------          -------
<S>                                    <C>
        12/1/97 to 11/30/98

        12/1/98 to 11/30/99

        12/1/99 to 11/30/00

        12/1/00 to 11/30/01

        12/1/01 to 2/28/02

        12/1/02 to 11/30/03

        12/1/03 to 2/28/05
</Table>

McGaw shall have the right to terminate this Agreement if Customer fails to meet
McGaw's published payment terms.

It is anticipated that the Current Agreement's annual dollar volume base will
increase from                ) to                    as a result of the addition
of the three (3) new product categories stated above in the Product Category
section of the this Amendment. Should Customer increase its annual dollar volume
purchases of McGaw products as a result of acquiring any company involved in
home I.V. therapy, under an I.V. agreement with McGaw, the incremental annual
dollar volume increase from the acquisition shall be calculated         and that
       shall be used to proportionately increase the above Agreement early
termination penalties.

ACQUISITION REVIEW

Should Customer acquire a company involved in home I.V. therapy whose primary
I.V. supplier is             and should be the annual unit purchases of the
acquired company in the twelve (12) designated product categories be included
under this Agreement, then, McGaw shall provide to Customer

within sixty (60) days of the close of Customer's acquisition.

<PAGE>

                                                                      (REDACTED)

Mr. Robert F. Roose, Jr.
December 15, 1997
Page 4

ADDITIONAL PRICING

Pricing additions and/or reductions to this Agreement are attached hereto as
Exhibit II and shall be included under all provisions covering price protection
as modified in this Amendment.

With our signature below, this Amendment will become part of our existing
Agreement.

Very truly yours,                              Accepted by:

/s/ WILLIAM C. WARNER                          /s/ ROBERT F. ROOSE, JR.
                                               ---------------------------------
William C. Warner                              (Authorized Signature)
Manager, Corporate Accounts

WCW:nl

                                                     Robert F. Roose, Jr.
                                                   V.P. Materials Management
                                               ---------------------------------
                                               (Printed or Typed name and Title)

                                                           12/18/97
                                               ---------------------------------
                                               (Date)

<PAGE>

                                                                      (REDACTED)

                                   EXHIBIT II

                                 B. BRAUN/MCGAW
                           MODIFIED AGREEMENT PRICING
                                       FOR
                                CORAM HEALTHCARE

<Table>
<Caption>
CATALOG                                                    UNITS PER          PRICE           PRICE
NUMBER               DESCRIPTION                              CASE            EACH            CASE
-----------          -----------                           ---------          -----           -----
<S>                  <C>                                   <C>                <C>             <C>
S9980-10             HyperFormer Formulator Bag 1L
S9985-10             HyperFormer Formulator Bag 2L
S9986-10             HyperFormer Formulator Bag 3L
S9980-10             HyperFormer Formulator Bag 1L
S9981-10             HyperFormer Formulator Bag 500ml
S9990-10             Non-McGaw Formulator Bag 1L
S9995-10             Non-McGaw Formulator Bag 2L
S9996-10             Non-McGaw Formulator Bag 3L
S9916-10             TPN Bag, 3 lead, non-dehp, 3L

NF1310               MICRO EXT W/INJ SITE
NF1318               MICROBORE "Y" EXT.
NF3482               ADULT BASIC Q/1 Y-SITE
NF9280               VIAL ACCESS/MULTI-DOSE
NF1450               SEC/TURN LOCK
NF3485               ADULT ADD. W/2 Y-SITES
NF5300               RATEFLOW-SAFELINE EXT SET
NF9100               INJECTION SITE
NF9206               SECURE LOCK CANNULA
NF9210               BLUNT CANNULA
NF9285               MEDIC PLASTIC ANTI-STICK NDL
NF9200               CLIP LOCK CANNULA

N8050-050            50mL volume-50mL/hr
N8100-100            100mL volume-100mL/hr
N8100-200            100mL volume-200mL/hr
N8250-050            250mL volume-50mL/hr
N8250-167            250mL volume-167ml/hr
</Table>

                                   Page 1 of 1                          10/20/97

<PAGE>
                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

February 2, 1998

Randy Sanger
Director, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Randy:

Please consider this letter as an addendum to current Coram Healthcare Agreement
with B. Braun McGaw commencing December 1, 1995.

B. Braun McGaw is pleased to add and/or modify pricing on the following catalog
numbers. Please insure that these code numbers are approved as PREFERRED
PRODUCTS under the Legacy System.

<Table>
<Caption>
Catalog                                                                   Units     Price       Price
Number          Description                                                Case     Each        Case
------          -----------                                               -----     -----       -----
<S>             <C>                                                       <C>       <C>         <C>
NF1318          Extension Set with Y-Type Microbore extension set
                with attached Safeline Injection site, female adapter,
                two removable slide clamps, male luer lock. Priming
                Volume: 0.45mL, 17 inches

NF1331          Extension set with SafeLine inj. site, female adapter,
                microbore tubing, removable slide clamp, male luer
                lock, Priming volume: 0.64mL, 17 inches

NF1342          T-Connector Extension Set with female adapter,
                microbore tubing, removable slide clamp, male
                adapter 3/4-connector with SafeLine injection site.
                Priming Volume; 0.45mL, 6 inches

V9900-02        HyperFormer(TM) Pump dispensing set for use with dual
                chamber mixing bags
</Table>

All other terms and conditions shall be in accordance with your existing
contract with B. Braun McGaw, including any subsequent addenda.

Thank you for your continued use of B. Braun McGaw products. We would appreciate
your signing and returning one copy of this letter in the stamped,
self-addressed envelope, which is enclosed. Should you have any questions
regarding this addendum, please contact our Denver National Accounts office at
(303) 220-7111.

Very truly yours,                              Accepted by:

/s/ WILLIAM C. WARNER

William C. Warner                              /s/ RANDY SANGER
Manager, Corporate Accounts                    ---------------------------------
                                               (Authorized Signature)

                                               Randy Sanger
                                               ---------------------------------
                                               (Printed or Typed name and Title)

                                               2/2/98
                                               ---------------------------------
                                               (Date)

<PAGE>
                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

          February 16, 1998

          Randy Sanger
          Director, Materials Management
          Coram Healthcare
          1125 Seventeenth Street, Suite 2100
          Denver, CO 80202

          Dear Randy:

          Please consider this letter as an addendum to current Coram Healthcare
          Agreement with B. Braun McGaw commencing December 1, 1995.

          B. Braun McGaw is pleased to add and/or modify pricing on the
          following catalog numbers. Please insure that these code numbers are
          approved as PREFERRED PRODUCTS under the Legacy System.

<Table>
<Caption>
          Catalog                                      Units     Price     Price
          Number    Description                        Case      Each      Case
          ----------------------------------------------------------------------
<S>                 <C>                                <C>       <C>       <C>

                    800 mg:
          ----------------------------------------------------------------------
          P5540     0.08% Theophyline in 5% Dextrose
                    Injection
                    USP (0.8 mg/mL)           1000mL
          P5581     0.16% Theophyline in 5% Dextrose
                    Injection
                    USP (1.6 mg/mL)            500mL
          ----------------------------------------------------------------------
                    400 mg:
          ----------------------------------------------------------------------
          P5541     0.08% Theophyline in 5% Dextrose
                    Injection
                    USP (0.8 mg/mL)            500mL
          P5582     0.16% Theophyline in 5% Dextrose
                    Injection
                    USP (1.6 mg/mL)            250mL
</Table>

          All other terms and conditions shall be in accordance with your
          existing contract with B. Braun McGaw, including any subsequent
          addenda.

          Thank you for your continued use of B. Braun McGaw products. We would
          appreciate your signing and returning one copy of this letter in the
          stamped, self-addressed envelope, which is enclosed. Should you have
          any questions regarding this addendum, please contact our Denver
          National Accounts office at (303) 220-7111.

          Very truly yours,                    Accepted by:

          /s/ WILLIAM C. WARNER                /s/ RANDY SANGER
                                               ---------------------------------
          William C. Warner                    (Authorized Signature)
          Manager, Corporate Accounts

                                               ---------------------------------
                                               (Printed or Typed name and Title)
          cc: Barbara Thomas, Coram
                                               ---------------------------------
                                               (Date)

<PAGE>
                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

March 5, 1998

Randy Sanger
Director, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Randy:

Please consider this letter as an addendum to current Coram Healthcare
Agreement with B. Braun McGaw commencing December 1, 1995.

B. Braun McGaw is pleased to add and/or modify pricing on the following catalog
numbers. Please insure that these code numbers are approved as PREFERRED
PRODUCTS under the Legacy System.

<Table>
<Caption>
Catalog                                            Units     Price     Price
Number         Description                         Case      Each      Each
------         -----------                         -----     -----     -----
<S>            <C>                                <C>       <C>       <C>

473105         Extension set with Microbore
(ET112SB)      tubing and SPIN-LOCK(R) Connector.
               12 inches Priming volume 0.4ml

472064         Small bore extension set with
(ET116SL)      SAFSITE(R) valve, SPIN-LOCK(R)
               connection, length 6 in. Priming
               volume 0.4 ml
</Table>

All other terms and conditions shall be in accordance with your existing
contract with McGaw, including any subsequent addenda.

Thank you for your continued use of McGaw products. We would appreciate your
signing and returning one copy of this letter in the stamped, self-addressed
envelope, which is enclosed. Should you have any questions regarding this
addendum, please contact our Denver National Accounts office at (303) 220-7111.

Very truly yours,                                    Accepted by:

/s/ WILLIAM C. WARNER                                /s/ RANDY SANGER
                                                     ---------------------------
William C. Warner                                    (Authorized Signature)
Manager, Corporate Accounts
                                                     Randy Sanger
                                                     ---------------------------
                                                     (Printed or Typed name and
                                                      Title)

cc: Barbara Thomas, Coram                             3/17/98
                                                     ---------------------------
                                                     (Date)

<PAGE>
                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

March 5, 1998

Randy Sanger
Director, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Randy:

Please consider this letter as an addendum to current Coram Healthcare
Agreement with B. Braun McGaw commencing December 1, 1995.

B. Braun McGaw is pleased to add and/or modify pricing on the following catalog
numbers. Please insure that these code numbers are approved as PREFERRED
PRODUCTS under the Legacy System.

<Table>
<Caption>
Catalog                                                    Units   Price   Price
Number      Description                                     Case    Each    Case
-------     -----------                                    -----   -----   -----
<S>         <C>                                            <C>     <C>     <C>
NF3486      Filtered Administration Set (15 Drops/MmL)
            Two slide clamps, SafeLine injection sites 6"
            and 84" above distal end, Control clamp,
            Trimed(R) Low Pressure Filter (0.22u), two
            piece male luer lock. Priming Volume: 20 mL

</Table>

All other terms and conditions shall be in accordance with your existing
contract with McGaw, including any subsequent addenda.

Thank you for your continued use of McGaw products. We would appreciate your
signing and returning one copy of this letter in the stamped, self-addressed
envelope, which is enclosed. Should you have any questions regarding this
addendum, please contact our Denver National Accounts office at (303) 220-7111.

Very truly yours,                       Accepted by:

/s/ WILLIAM C. WARNER                   /s/ RANDY SANGER
                                        ----------------------------------------
William C. Warner                       (Authorized Signature)
Manager, Corporate Accounts
                                        Randy Sanger
                                        ----------------------------------------
                                        (Printed or Typed name and Title)
cc: Barbara Thomas, Coram
                                        3/17/98
                                        ----------------------------------------
                                        (Date)

<PAGE>
                                                                      (REDACTED)

                               [MCGAW LETTERHEAD]

March 10, 1998

Robert F. Roose, Jr.
Vice President,
Materials Management
Coram Healthcare
1125 Seventeenth St., Suite 2100
Denver, CO 80202

Dear Bob:

This is an Amendment to the current McGaw and Coram Healthcare Agreement
effective December 1, 1995 through February 28, 2005, as amended on December
15, 1997.

HIGH SPEED COMPOUNDING EQUIPMENT

The provisions of this paragraph in the Current Agreement shall be replaced with
the following:

     Customer agrees to use McGaw Single Chamber Mixing Bags                ,
     Customer agrees to replace Automix units with a HyperFormer system within a
     twelve (12) month period immediately following the introduction of a tested
     and functional HyperFormer/Legacy system computer interface. Until
     expiration of the twelve (12) month Automix to HyperFormer transition
     period, continued use of Automix compounders shall not constitute non
     compliance under the TPN Compounding Equipment and Mixing Bags Product
     Category. Customer may, at Customer's discretion, add McGaw dual chamber
     mixing bags to the TPN Compounding Equipment and Mixing Bags Product
     Category providing quality and price meet Customer's approval.

With our signatures below, this Amendment shall become part of our existing
Agreement.

Very truly yours,                       Approved by:

/s/ WILLIAM C. WARNER                   /s/ ROBERT ROOSE
                                        ---------------------------------------
William C. Warner                       Signature
Manager, National Accounts

WCW:nl                                  Robert Roose
                                        ---------------------------------------
                                        Printed Name

                                        3/23/98
                                        ---------------------------------------
                                        Date
<PAGE>
                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

March 10,1998

Robert F. Roose, Jr.
Vice President,
Materials Management
Coram Healthcare
1125 Seventeenth St., Suite 2100
Denver, CO 80202

Dear Bob:

This is an Amendment to the current McGaw and Coram Healthcare Agreement
effective December 1, 1995 through February 28, 2005, as amended on December 15,
1997.

HIGH SPEED COMPOUNDING EQUIPMENT

The provisions of this paragraph in the Current Agreement shall be replaced with
the following:

Customer agrees to use McGaw Single Chamber Mixing Bags

    Customer agrees to replace Automix units with a HyperFormer system within a
twelve (12) month period immediately following the introduction of a tested and
functional HyperFormer/Legacy system computer interface. Until expiration of the
twelve (12) month Automix to HyperFormer transition period, continued use of
Automix compounders shall not constitute non compliance under the TPN
compounding Equipment and Mixing Bags Product Category. Customer may, at
Customer's discretion, add McGaw dual chamber mixing bags to the TPN Compounding
Equipment and Mixing Bag Product Category providing quality and price meet
Customer's approval.

With our signatures below, this Amendment shall become part of our existing
Agreement.

Very truly yours,                       Approved by:

/s/ WILLIAM C. WARNER                   /s/ RANDY SANGER
                                        -------------------------
William C. Warner                       Signature
Manager, National Accounts

WCW:nl                                  Randy Sanger
                                        -------------------------
                                        Printed Name

                                        3/17/98
                                        -------------------------
                                        Date
<PAGE>
                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

May 14, 1998

Robert F. Roose, Jr.
Vice President,
Materials Management
Coram Healthcare
1125 Seventeenth St., Suite 2100
Denver, CO 80202

Dear Bob:

This is an Amendment to the current McGaw and Coram Healthcare Agreement
effective December 1, 1995 through February 28, 2005, as amended on December
15, 1997.

SPECIAL INCENTIVES

The provisions of these paragraphs shall be amended to include the following.
McGaw shall excuse customer from the                                compliance
requirement covering the Needle Free Sets and Components product category
through August 31, 1998. During this time period, McGaw shall continue to pay
to Customer the                                               for the remaining
eleven (11) product categories purchased by Customer as per the Agreement.

With your signature below, this Amendment shall become part of our existing
Agreement.

Very truly yours,                         Accepted by:

/s/ WILLIAM C. WARNER                     /s/ RANDY SANGER
                                          --------------------------------------
William C. Warner                         Signature
Manager, National Accounts

WCW:nl                                    Randy Sanger
cc: Randy Sanger                          --------------------------------------
                                          Printed Name

                                          6/15/98
                                          --------------------------------------
                                          Date

<PAGE>
                                                                      (REDACTED)

                               (MCGAW LETTERHEAD)

July 15, 1998

Randy Sanger
Director, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Randy:

Please consider this letter as an addendum to the current Coram Healthcare
Agreement with B. Braun McGaw commencing December 1, 1995.

B. Braun McGaw is pleased to add and/or modify pricing on the following catalog
numbers. Please insure that these code numbers are approved as PREFERRED
PRODUCTS under the Legacy System.

<Table>
<Caption>

Catalog                                                  Units      Price     Price
Number       Description                                 Case       Each      Case
-------      -----------------------------------------   -----      -----     -----
<S>         <C>                                          <C>        <C>       <C>
CFE2012     0.2 Micron charged SUPOR(R) Filter
473043      extension set endotoxin retentive,
            air eliminating in-line IV filter
            with on/off clamp, latex free
            Y-injection site and distal SPIN-LOCK(R)
            connection. DEHP free tubing. Printing
            volume 0.4mL,length 14 in.

DP1000      MINI-SPIKE(R)IV Additive Disp
            preparing and dispensing diluer
            multi-dose rubber-stoppered vial
            bacterial retentive air-venting fil
</Table>

All other terms and conditions shall be in accordance with your existing
contract with McGaw, including any subsequent addenda.

Thank you for your continued use of McGaw products. We would appreciate your
signing and returning one copy of this letter in the stamped, self-addressed
envelope, which is enclosed. Should you have any questions regarding this
addendum, please contact our Denver National Accounts office at (303) 220-7111.

Very truly yours,

/s/ WILLIAM C. WARNER                        /s/ RANDY SANGER
                                             ----------------------------------
William C. Warner                            (Authorized Signature)
Manager, Corporate Accounts

                                             /s/ Randy Sanger
                                             ----------------------------------
                                             (Printed or Typed name and Title)

(STAMP)
<PAGE>

                                                                      (REDACTED)

                           (B. BRAUN & MCGAW LETTERHEAD)

November 16, 1998

Armand Paladino
Biomedical Services Manager
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Armand:

Please consider this correspondence an addendum to and an integral part of the
current B. Braun McGaw and Coram Healthcare Agreement effective December 1, 1994
and running through February 28, 2001, and, the Agreement Addendum dated May 29,
1996, extending the Agreement Term through February 28, 2003.

B. Braun McGaw agrees to supply an additional six (6) refractometer units to the
eighty (80) refractometer units currently in place (VWR catalog number
55680-506,                 to designated Coram Pharmacies at          Ownership
of all refractometer inventories will remain with B. Braun McGaw. Designated
Coram pharmacies shall have unlimited use of all refractometer units during the
Agreement Term. At the conclusion of the Agreement Term, all refractometer
inventory shall be returned to B. Braun McGaw or be purchased by Coram at the
price of                              . Simple straight line depreciation was
used to determine residual value.

With our signatures below, this amendment will become part of our existing
Agreement.

Very truly yours,                    Accepted by:

/s/ WILLIAM C. WARNER                /s/ ARMAND F. PALADINO
                                     ------------------------------------------
William C. Warner                    Signature
Director, National Accounts

WCW:nl                               Armand F. Paladino/Biomedical Services Mg.
                                     ------------------------------------------
                                     Printed name and Title

                                     11/18/98
                                     -------------------------------------------
                                     Date

                                                                         (STAMP)
<PAGE>
                                                                      (REDACTED)

                          (B.BRAUN & MCGAW LETTERHEAD)

September 15, 1999

                                                                         (STAMP)
Mr. Robert F. Roose, Jr.
Senior Vice President
Chief Purchasing Officer
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Bob:

This letter is an amendment ("Third Amendment") to the current McGaw, a.k.a
B.Braun/McGaw, and Coram Healthcare Agreement effective December 1, 1995,
through February 28, 2001, (hereinafter referred to as "Current Agreement") and
the amendments dated May 29, 1996, extending the Current Agreement through
February 28, 2003 (hereinafter referred to as "First Amendment") and the
Amendment dated December 15, 1997, extending the Current Agreement through
February 28, 2005, (hereinafter referred to as the "Second Amendment").

PRODUCT CATEGORIES

The provisions of this paragraph in the Current Agreement and First and Second
Amendments shall be modified as follows: (1) needle free sets and components
are removed as a product category; and (2) dual chamber TPN mixing bags are
added as an additional product category. Full conversion to dual chamber TPN
mixing bags shall commence on or before January 1, 2000 providing field trials
are completed and customized inventory is available. Customer shall also make a
determined and conscientious effort to convert all standard TPN mixing bag
volume to McGaw, a.k.a. B.Braun/McGaw.

SPECIAL INCENTIVES

Provisions of this paragraph in the Current Agreement and in the First and
Second Amendments are replaced with the following: effective November 1, 1999,
the                                    , is hereby terminated.

SYNTHETIC AMINO ACID COST ADJUSTMENT

Commencing November 1, 1999, McGaw a.k.a. B.Braun/McGaw agrees to pay to
Customer a quarterly rebate in the amount of          Customer'
in a specifically defined patient group. The     shall be paid in the form of a
Credit Memorandum forty five (45) days from the close of each calendar quarter.
McGaw a.k.a B.Braun/McGaw also agrees to provide a monthly
purchases by Customer's pharmacies.
<PAGE>
                                                                      (REDACTED)

                                                        Mr. Robert F. Roose, Jr.
                                                              September 15, 1999
                                                                          Page 2

TERMINATION

Provisions of this paragraph in the Current Agreement and in the First and
Second Amendments are replaced with the following:

Customer shall have the right to terminate this Agreement after sixty (60) days
written notice if McGaw, a.k.a. B. Braun/McGaw, provides product or service of
quality or technical level which fail to meet ordinary standards of the medical
care industry. Should Customer or any acquiror, or other successor in interest,
of Customer desire to terminate this Agreement for any other reason, Customer
shall give to McGaw, a.k.a. B. Braun/McGaw, a six (6) month written notice of
such intent. In such event, Customer shall reimburse McGaw, a.k.a.
B. Braun/McGaw: 1)                          referred to in the Current Agreement
and modified in the First Amendment and the                            referred
to in the Second Amendment, both of which have been prorated over the remaining
term of this Agreement at a combined rate of                        per
uncompleted quarter plus 2) higher of                      or
for the 12 months immediately preceeding the early termination. Said combined
sums shall be paid within sixty (60) days of the early termination date.

PRICE PROTECTION

The provision of this paragraph in the Current Agreement and the First and
Second Amendments shall be replaced with the following:

Pricing will be held firm for the first period December 1, 1995 to October 31,
1999. A two and one-half (2.5) percent price increase shall be implemented
November 1, 1999. Price increases for the sixth (6th), seventh (7th) and eighth
(8th) Agreement years (December 1, 2000 to November 30, 2003), and the remaining
fifteen (15) month period, (December 1, 2003 to February 28, 2005), shall be
limited to a maximum of two and one-half percent (2.5%) or the CPI whichever is
lower.

OTHER PROVISIONS

Customer agrees to remain with its current needle free system and give McGaw,
a.k.a. B. Braun/McGaw, a reasonable opportunity to reinstate one of its needle
free systems as a primary product category under the Current Agreement on or
before March 1, 2002. Upon reinstatement of its needle free system as a primary
product category and                             to the products usage, McGaw,
a.k.a. B. Braun/McGaw, shall                               annual
on purchases made from that point in time.
<PAGE>
                                                        Mr. Robert F. Roose, Jr.
                                                              September 15, 1999
                                                                          Page 3

With your signature below, this Third Amendment will become part of our existing
Current Agreement. All other terms and conditions are unchanged.

Very truly yours                             Accepted by:

/s/ WILLIAM C. WARNER                        /s/ ROBERT F. ROOSE, JR.
                                             ----------------------------------
William C. Warner                            (Authorized Signature)
Director, National Accounts

                                             Robert F. Roose, Jr.
                                             ----------------------------------
                                             Senior Vice President, Chief
                                             Purchasing Officer

                                             10/3/99
                                             ----------------------------------
                                             (Date)
<PAGE>
                                                                      (REDACTED)

                       (B. BRAUN MEDICAL INC. LETTERHEAD)

March 29, 2000

Robert F. Roose, Jr
Senior Vice President, Chief Purchasing Officer
Coram Healthcare
1125 Seventeenth Street
Suite 2100
Denver, Colorado 80202

Dear Bob:

This letter is an Amendment to the current agreement between Coram Healthcare
("Coram") and B. Braun Medical Inc., successor in interest by merger with McGaw,
Inc., dated on or about December 1, 1995, as amended May 29, 1996, and December
15, 1997 (the "Agreement"), which expires February 28, 2005.

The Agreement is hereby amended to add Coram's custom-designed dual chamber TPN
mixing bags, as described on the attached schedule (the "Custom Products") to
the list of Products to be purchased by Coram, and supplied by B. Braun under
the Agreement. The Custom Products shall be classified as a product under the
TPN Compounding Equipment and Mixing Bag Product Category in the Agreement.

The Custom Products are manufactured by            pursuant to the
specifications of Coram, and B. Braun, as distributor of the Custom Products
shall supply the Custom Product to Coram under the terms and conditions of the
Agreement, as modified by this Amendment. B. Braun, as distributor of the Custom
Products, makes no product warranties with respect to the Custom Products, and
Coram must instead rely on the representations and warranties, if any, provided
directly to Coram by Stedim, Inc.

Pricing for the Custom Products is set forth on the attached schedule, and is
exclusive of all freight, handling, taxes and insurance. Such pricing is
contingent upon Coram purchasing a minimum combined total of         Custom
Products during each twelve month period from the date hereof ("Contract
Year"). Provided there is no default, or any event with which the passage of
time or the giving of notice would result in an event of default under the
Agreement, if the annual combined purchases of Custom Products during any
Contract Year exceeds         units, B. Braun will issue a rebate to Coram in
the amount of
             The rebate will be

The Agreement is hereby incorporated in this Amendment as if fully set forth
herein. Except as specifically modified and amended herein, all the terms and
conditions of the Agreement shall remain in full force and effect without
modification, and are hereby ratified and affirmed. All references to the
Agreement shall mean the Agreement as modified and amended by this Amendment.

<PAGE>
                                                            Robert F. Roose, Jr.
                                                                  March 29, 2000
                                                                          Page 2

Intending to be legally bound, hereby, with your signature below, this
Amendment shall become part of our existing Agreement.

Very truly yours,                              Accepted by:

/s/ WILLIAM C. WARNER                          ROBERT F. ROOSE, JR.
                                               ---------------------------------
William C. Warner                              Signature
Director, National Accounts
                                               Robert F. Roose, Jr.
                                               ---------------------------------
                                               Printed Name

                                               3/29/00
                                               ---------------------------------
                                               Date
<PAGE>
                                                                      (REDACTED)

                                B. Braun Medical

                         Dual Chamber Mixing Bag Prices
                                      for
                                CORAM HEALTHCARE

<Table>
<Caption>
Catalog                              Size   Units   Price    Price    Volume    Net Price   Net Price   Estimated Annual
Number    Description                (mL)   (case)  Each     Case    Incentive     Each        Case       Unit Volume
-------   -----------                ----   ------  -----    -----   ---------  ---------   ---------   ----------------
<S>       <C>                        <C>    <C>     <C>      <C>     <C>        <C>         <C>         <C>

CH1500    Dual Chamber Mixing Bag,   1500
          EVA Formulation, Latex
          Free, with HyperFormer
          or Automix compatible
          connector USC1522

CH3000    Dual Chamber Mixing Bag,   3000
          EVA Formulation, Latex
          Free, with HyperFormer
          or Automix compatible
          connector USC3022

CH4000    Dual Chamber Mixing Bag,   4000
          EVA Formulation, Latex
          Free, with HyperFormer
          or Automix compatible
          connector

                                Total

</Table>
<PAGE>
                                                                      (REDACTED)

                           Annual Dual Chamber Usage
                                      for
                                Coram Healthcare

<Table>
<Caption>

                                                                       AUTOMIX                         HYPERFORMER
                                                     Automix/Automix            Automix/Spike     HyperFormer/HyperFormer
PHARMACY                                        1500 mL  3000 mL   4000 mL    1500 mL   3000 mL     1500 mL     3000 mL
                                                USC1522  USG3022   USC4022    USC1520   USC3020     USC1521     USC3021
City           Territory Manager   State    HSC   Units    Units     Units      Units     Units       Units       Units     Comments
----           -----------------   -----    --- -------  -------   -------    -------   -------   ---------     ---------   --------
<S>            <C>                 <C>      <C> <C>      <C>       <C>        <C>       <C>      <C>            <C>         <C>
Birmingham     Tom Foster          AL        H
Phoenix        Chuck Meisel        AZ        A
Bakersfield    Marlene O'Tousa     CA        A
Glendale       Marlene O'Tousa     CA        A
Ontario        Marlene O'Tousa     CA        A
San Diego      Katie MacDonald     CA        A
San Francisco  Trish Anderman      CA        H
Santa Barbara  Marlene O'Tousa     CA        A
Tustin         Katie MacDonald     CA        A
Denver         James Miller        CO        H
Waterbury      Chris Carelli       CT        A
Tampa          Lee Sims            FL        A/H
Jacksonville   Lee Sims            FL        H
Atlanta        Lisa Wilkes         GA        A
Honolulu       Open                HI        A
Davenport      Kristi Testrake     IA        A
Boise          James Chung         ID        A
Chicago        Carol Hoffer        IL        A
Fort Wayne     John Faulkner       IN        A
Indianapolis   John Faulkner       IN        A
Wichita        Rob Fisher          KS        A
Lenexa         Rob Fisher          KS        H
</Table>

Coram Duel Usage/Rvsd DC by State                                Printed: 8/2/01
<PAGE>
                                                                      (REDACTED)

                       (B. BRAUN MEDICAL INC. LETTERHEAD)

September 18, 2000

Frank Geiger
Senior Vice President, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Frank:

Please consider this letter as an addendum to the current Coram Healthcare
Agreement with B. Braun Medical commencing December 1, 1995.

B. Braun Medical is pleased to modify pricing on the following catalog number.
Please insure that this code number is approved as a PREFERRED PRODUCT under the
Legacy System.

<Table>
<Caption>
Catalog                                                             Units   Price   Price
Number     Description                                              Case    Each    Case
-------    -----------                                              -----   -----   -----
<S>        <C>                                                      <C>     <C>     <C>
471993     Small Bore Y Extension Set w/SAFSITE(R) valve
           and luer lock connection. Total Priming Volume:
           0.50 mL, Length 6 in.

471994     Small Bore Y Extension Set w/SAFSITE(R) valve
           and SPIN-LOCK connection. Total Priming
           Volume: 0.50 mL, Length 6 in.

415110     ULTRASITE positive pressure valve for aspiration,
           injection or gravity flow of fluid upon insertion of a
           male luer fitting. Priming Vol: 0.35 mL

473442     Small bore Y-extension set with ULTRASITE valve
           and SPIN-LOCK connection. Priming Volume:
           0.70mL, Length: 6 in.
</Table>

All other terms and conditions shall be in accordance with your existing
contract with B. Braun Medical, including any subsequent addenda.
<PAGE>
                                                                    Frank Geiger
                                     Senior Vice President, Materials Management
                                                              September 18, 2000
                                                                          Page 2

Thank you for your continued use of B. Braun Medical products. We would
appreciate your signing and returning one copy of this letter in the stamped,
self-addressed envelope, which is enclosed. Should you have any questions
regarding this addendum, please contact our Denver National Accounts office at
(303) 220-7111.

Very truly yours,                       Accepted by:

/s/ WILLIAM C. WARNER                   /s/ FRANK GEIGER
                                        -----------------------------------
William C. Warner                       (Authorized Signature)
Director, Corporate Accounts

                                        Frank Geiger    Sr. VP MM
                                        -----------------------------------
                                        (Printed or Typed name and Title)

                                          9/29/00
                                        -----------------------------------
                                        (Date)

(STAMP)
<PAGE>
                       (B. BRAUN MEDICAL INC. LETTERHEAD)

November 10, 2000

Frank Geiger
Senior Vice President, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Frank:

Please consider this letter as an addendum to the current Coram Healthcare
Agreement (Contract number AS62441795) with B. Braun Medical commencing
December 1, 1995.

B. Braun Medical is pleased to add and/or modify pricing on the products listed
on the attached price list. Please insure that these code numbers are approved
as PREFERRED PRODUCTS under the Legacy System.

To simplify administrative procedures, all B. Braun Heritage products have been
consolidated under the above Agreement and these products will be included in
all future rebate calculations. All other terms and conditions shall be in
accordance with your existing contract with B. Braun Medical, including any
subsequent addenda.

Thank you for your continued use of B. Braun Medical products. We would
appreciate your signing and returning one copy of this letter in the stamped,
self-addressed envelope, which is enclosed. Should you have any questions
regarding this addendum, please contact our Denver National Accounts office at
(303) 220-7111.

Very truly yours,                              Accepted by:

/s/ WILLIAM C. WARNER                          /s/ FRANK GEIGER
                                               ---------------------------------
William C. Warner                              (Authorized Signature)
Director, Corporate Accounts
                                               Frank Geiger               Sr. VP
                                               ---------------------------------
                                               (Printed or Typed name and Title)

                                               11/13/2000
                                               ---------------------------------
                                               (Date)
<PAGE>

                                 B. Braun/McGaw
                            Price List Prepared for
                                Coram Healthcare
                               Effective 11/1/99

                                    Redacted
<PAGE>
                                                                      (REDACTED)

                       (B. BRAUN MEDICAL INC. LETTERHEAD)

March 30, 2001

Frank Geiger
Senior Vice President, Materials Management
Coram Healthcare
1125 Seventeenth Street, Suite 2100
Denver, CO 80202

Dear Frank:

As per the terms and conditions of B. Braun Medical's IV Solutions Agreement
with Coram Healthcare dated November 17, 1995, to include all Amendments,
          percent price increase was due on December 1, 2000. However, due to
Coram Healthcare's participation under Chapter 11 proceedings, B. Braun Medical
elected to postpone any pricing adjustments to allow Coram Healthcare full
opportunity to reestablish its financial position.

Now that Coram Healthcare's economic base is secure, the following alternative
is offered. B. Braun Medical hereby waives the
                                                  initiated November 1, 1999.

If you are in agreement with the proposed modification, please sign in the
signature block provided and return the document to my attention in the
self-addressed, stamped envelope provided.

B. Braun Medical sincerely appreciates the opportunity to serve Coram
Healthcare's IV solution requirements. We highly value the mutually beneficial
business relationship that has developed and trust that our proposal will meet
with your approval.

Please feel free to call me if you have any questions. Thank you again for all
your support.

Very truly yours,                            Accepted by:

/s/ WILLIAM C. WARNER                        /s/ FRANK GEIGER
                                             ----------------------------------
William C. Warner                            (Authorized Signature)
Director, National Accounts

                                             Frank Geiger    Sr. Vice Pres., MM
                                             ----------------------------------
                                             (Printed or Typed name and Title)

                                             4/16/01
                                             ----------------------------------
                                             (Date)
<PAGE>
                                                                      (REDACTED)

                       (B. BRAUN MEDICAL INC. LETTERHEAD)

January 3, 2002

Frank Geiger
Senior Vice President,
Materials Management
Coram Healthcare
1675 Broadway, Suite 900
Denver, CO 80202

Dear Frank:

In accordance with the terms and conditions of the current Agreement between
Coram Healthcare and B. Braun Medical commencing December 1, 1995 and running
through February 28, 2005, to include the Agreement Amendment dated March 29,
2000, B. Braun hereby requests Coram's confirmation and approval of the
following:

1.  The proposed modifications to the       manufactured Dual Chamber Bag Spike
    Port and IV Medication Port as detailed on the attached technical drawings.
    It is understood that the medication port is an interim design which will be
    replaced by a larger medication port by the end of 2002 and/or once parts
    are qualified by Stedim. A sample of the final medication port has been sent
    to Stephen Schmidt.

2.  Coram will purchase a minimum of       Custom Dual Chamber Bags annually or

               of its Dual Chamber Bag requirements under the designated "TPN
    Compounding Equipment and Mixing Bag" Product Category. Current pricing is
    based upon annual minimum purchasing quantities. Future modifications to bag
    designs may result in pricing increases. Coram is currently purchasing
    Custom Dual Chamber Bags at a rate of       units per year.

3.  The Dual Chamber Bags manufactured by         and distributed by B. Braun
    are custom products designed to Coram's specifications as mutually agreed
    upon and defined in the attached technical drawings. Both         and B.
    Braun have made a conscientious effort to meet these requirements.

4.  Authorization of continued production of         Custom Dual Chamber Bags
    with approved modifications. Coram shall have the right to discontinue
    purchase of        Custom Dual Chamber Bags after 180 days written notice if
    B. Braun fails to provide product or service of a quality or technical level
    which fails to meet ordinary standards of the medical care industry. Upon
    submission of termination notification, Coram agrees to continue to purchase
    either of its Custom Dual Chamber Bag requirements from B. Braun through out
    the 180 day period or purchase all                            in B. Braun's
    possession and all Custom Dual Chamber Bag in process materials, whichever
    is less.

<PAGE>
                                                                      (REDACTED)

                                                                    Frank Geiger
                                                                 January 3, 2002
                                                                          Page 2

5. Upon release of the modified Custom Dual Chamber Bags, Coram will continue to
   purchase inventory on a first-in, first-out basis. However, a determined
   effort will be made to supply only modified inventory to selected pharmacies
   if possible.

We sincerely appreciate the opportunity to fulfill Coram's Custom Dual Chamber
Bag requirements and look forward to a continuation of this mutually beneficial
relationship in the future. Your signature in the space provided will confirm
Coram's acceptance of the provisions specified above.

Very truly yours,                            Accepted by:

/s/ WILLIAM C. WARNER                        /s/ FRANK GEIGER
                                             ---------------------------
William C. Warner                            Signature
Director, National Accounts
                                             Frank Geiger
                                             Sr. VP Materials Management
                                             ---------------------------
                                             Printed Name/Title

                                             1/9/02
                                             ---------------------------
                                             Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00052-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00052-of-00352.parquet"}]]